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A exposição humana a hidrocarbonetos aromáticos policíclicos (HAPs) pode 
advir de fogos florestais, combustão proveniente do carvão para fazer alcatrão, 
fumo do tabaco e fumo proveniente de tráfego rodoviário, podendo torna-se 
crítica em algumas áreas de residência ou tipos de trabalho. Os HAPs são 
considerados um grupo de químicos prioritários uma vez que são 
carcinogénicos, mutagénicos e teratogénicos. Portanto, é crucial monitorizar e 
estudar a exposição de populações humanas a HAPs principalmente durante o 
desenvolvimento fetal, que é considerada uma fase maís sensível à exposição 
a contaminantes. Neste contexto os principais objetivos deste estudo foram: 
(1) avaliar a exposição de HAPs nas parturientes e recém-nascidos da região 
de Aveiro usando como matrizes biológicas sangue e placenta; (2) examinar a 
influência ambiental, dados sociodemográficos, estilo de vida e hábitos 
tabágicos que podem contribuir para a exposição dos HAPs durante a gravidez 
na região de Aveiro, Portugal. 
Neste estudo participaram 49 mães e recém-nascidos da região de Aveiro. A 
amostragem efetuada (placenta, sangue do cordão umbilical e sangue das 
parturientes) e informações recolhidas foram aprovadas pelo Comité de Ética 
do Hospital Infante D. Pedro do Centro Hospitalar Baixo Vouga, Aveiro e todas 
as parturientes assinaram previamente consentimento informado. Foi utilizada 
espectrofotometria de fluorescência para efetuar a quantificação dos HAPs 
(homólogos de naftaleno, fenantreno, pireno e benzo[a]pireno) nos tecidos 
recolhidos. 
Em geral o grupo estudado apresentou elevados níveis de HAPs na placenta 
(fração total homogeneizada) e os níveis mais baixos no sangue do cordão 
umbilical. Os HAPs de baixo peso molecular (homólogos de naftaleno e 
fenantreno) que foram medidos na placenta, apresentaram níveis mais 
elevados que os níveis de HAPs de elevado peso molecular (homólogos de 
pireno e benzo[a]pireno) encontrados na placenta. Considerando o local de 
residência, os níveis de HAPs mais elevados na placenta foram encontrados 
em parturientes que habitavam em Aveiro, Ílhavo e Albergaria-a-Velha e os 
níveis mais baixos em Águeda. Além disso, o aumento dos níveis de 
homólogos de naftaleno e fenantreno na placenta foram associados à 
exposição a fumo proveniente de tráfego rodoviário e os elevados níveis de 
benzo[a]pireno foram associados com a exposição a tabaco no trabalho. Os 
níveis mais elevados de homólogos de naftaleno, fenantreno e benzo[a]pireno 
foram encontrados na placenta (fracção homogeneizada total) de parturientes 
que fumaram no terceiro trimestre de gravidez. Não foram porém encontradas 
correlações significativas entre os níveis de HAPs e os dados antropométricos 
dos recém-nascidos, mas foram em geral encontradas elevadas 
concentrações de HAPs em recém-nascidos com menor peso, perímetro 
cefálico e comprimento. 
Este projeto permitiu obter uma visão geral dos níveis de HAPs em 
parturientes do distrito de Aveiro, identificando as principais fontes de 
exposição a HAPs. Para além disso, verificou-se que a placenta acumula 
HAPs, mas não funciona como uma barreira total a estes compostos, uma vez 
que estes conseguem alcançar o sangue do cordão umbilical, podendo como 
tal vir a causar efeitos adversos nos recém-nascidos.  
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abstract 
 
Human exposure to polycyclic aromatic hydrocarbons (PAHs) can arise from 
forest fires, coal tar combustion, vehicle exhausts and tobacco smoke and can 
be critical in some residential and working areas. PAHs are considered a group 
of priority chemicals as they are carcinogenic, mutagenic and teratogenic. 
Therefore, is crucial to monitor and study human exposure to PAHs, namely 
during fetal development, which is considered a sensitive window of exposure 
to contaminants. In this context, the main objectives of this study were: (i) to 
assess maternal and fetal exposure to PAHs in parturient from the Aveiro 
region using samples of placenta and blood as biological matrices; (ii) to 
examine the influence of environmental, sociodemographic, lifestyle and 
smoking habits that may contribute to PAHs exposure during pregnancy in 
Aveiro region, Portugal.  
This study was performed in 49 mother/newborn pairs from Aveiro region. All 
the matrices sampled (placenta, umbilical cord blood and mothers’ blood) and 
information gathered was approved by Ethics Committee of Infante D. Pedro 
Hospital in Centro Hospitalar do Baixo Vouga, Aveiro and all the parturient 
previously signed an informed consent. A fluorescence spectrophotometer was 
used to quantify levels of PAHs (naphthalene, phenanthrene, pyrene and 
benzo[a]pyrene equivalents) in the tissues collected. 
In general, the studied group presented high levels of PAHs equivalents in the 
placenta (total homogenate fraction) and low levels in the umbilical cord blood. 
The low molecular weight PAHs (naphthalene and phenanthrene equivalents) 
measured in placenta presented higher levels than high molecular weight PAHs 
(pyrene and benzo[a]pyrene equivalents). Considering the county of residence, 
the highest PAHs levels in placenta were found in parturient from Aveiro, Ílhavo 
and Albergaria-a-Velha and the lowest in Águeda. Moreover, increased levels 
of naphthalene and phenanthrene equivalents were associated with mothers’ 
exposure to vehicle exhaust, while high levels of benzo[a]pyrene equivalents 
were associated with their exposure to tobacco smoke at work. The highest 
levels of naphthalene, phenanthrene and benzo[a]pyrene equivalents were 
found in homogenized placenta of mothers who smoked in the third trimester of 
pregnancy. No significant correlations were found between levels of PAHs 
equivalents present in biological tissues studied and anthropometric data of 
newborns, but in general, high PAHs levels were found in newborns groups 
with low weight, head circumference, and length.  
This work provided an overview of the PAHs levels on pregnant woman from 
the Aveiro district, identifying the main sources of exposure to PAHs. 
Furthermore, placenta do accumulate PAHs, but is not a complete barrier for 
those lipophilic compounds, since they seem to cross cell membranes reaching 
umbilical cord blood and potentially causing adverse effects in the newborns, 
such as, low weight, length and head circumference values, despite the lack of 
statistical significance. 
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Chapter I: General Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
1.1 Introduction 
 
Polycyclic aromatic hydrocarbons (PAHs) can be considered persistent organic 
pollutants in the environment  (Meire, Azeredo and Torres, 2007). Natural emissions are 
related to forest fires, volcanic eruptions, algal and bacterial synthesis, and deposition of 
organic matter, petroleum seeps and rock erosion that contain petroleum hydrocarbons 
(Abdel-Shafy and Mansour, 2015). In addition to natural origin sources there may also 
be PAHs of anthropogenic origin that can affect the environment and human health. 
Anthropogenic emissions arise from incomplete oil burn or fossil fuels combustion 
products (Kim et al., 2013). Abdel-Shafy and Mansour (2015) divided PAHs into three 
categories: pyrogenic, petrogenic and biological in the environment. Pyrogenic PAHs 
can occur under low oxygen levels or anaerobic conditions and high temperatures. 
These PAHs can occur through incomplete combustion of the motor fuels of vehicles or 
incomplete combustion of wood in forest fires. The petrogenic process is characterized 
by crude oil maturation. Most spills of crude oil products happen in the ocean or in fresh 
water and are associated with the transportation and the storage. The PAHs with the 
biological production may arise from bacteria and plants synthesis during the organic 
matter degradation (Abdel-Shafy and Mansour, 2015). 
There are anthropogenic sources that can affect the well-being of the humans 
resulting in carcinogenic, mutagenic and teratogenic effects. The PAHs contact with 
human can lead to repercussions in short or long term health effects. The principal short 
term health effects are related with eye and skin irritation and inflammation, nausea and 
vomit. The principal long term health effects can be cancer, kidney and liver damage, 
strokes and gene mutation (Kim et al., 2013). Life style can be a potential promoter of 
PAHs bioaccumulation.  Smoking can cause neuro-teratogenic and fetal brain impacts. 
This can explain future cognitive, emotional and behaviour problems in children 
(Machado et al., 2014). 
PAHs can become bioaccessible and be found in the blood or placenta through 
different mechanisms like facilitated diffusion, passive diffusion and active transport 
depending on PAHs intrinsic properties (Chen et al., 2014). In the tissues or organs, the 
PAHs can be metabolized by enzymes and then can be accumulated or excreted. The 
developing fetus and infants can be more sensitive to environmental toxicants than 
healthy adults. Maternal exposure to PAHs can be a fetal growth reduction factor 
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(preterm delivery and low birth weight), head circumference reduction and intrauterine 
restrictions (Chen et al., 2014). 
1.2 PAHs in environment 
 
PAHs structure can be influenced by the source (Kim et al., 2013). PAHs are 
organic compounds constituted by hydrogen, carbon and benzene rings (Kim et al., 
2013). PAHs classified as low molecular weight have 2 or 3 benzene rings like 
naphthalene and phenanthrene equivalents), respectively. PAHs with high molecular 
weight have 4 (pyrene equivalents), 5 (benzo[a]pyrene or BaP equivalents), 6 
(Benzo[ghi]-perylene equivalents) or 7 (indeno[1,2,3-cd]pyrene equivalents ) benzene 
rings (Urbancova et al., 2017). There are some characteristics attribute to the PAHs 
according the benzene rings. PAHs with fewer benzene rings (2 or 3) are usually found 
in volatile phase and PAHs with more benzene rings  (4 or more) usually are found in 
particulate state (Mohanraj, Dhanakumar and Solaraj, 2012). Larger PAHs compounds 
(4 or more benzene rings) were found at higher concentrations in autumn and winter 
compared with those from spring and summer. These occurrences happen because the 
PAHs aging process relays in volatilization of finer particles and then the condensation 
onto bigger particles. Another explanation for this event is that PAHs and other 
pollutant mixtures could merge with long-range transported aerosol in cold seasons 
(winter and autumn). Lai et al., (2011) suggested that higher PAHs concentrations are 
observed in winter and arise from coal combustion and forest fires. The gas phase PAHs 
are dominant in days with high temperatures (summer time or tropical regions) and 
particulate phase PAHs occur more frequently at low temperatures (winter time or arctic 
regions). The adsorption of PAHs from gas phase to the particulate phase can be related 
with humidity (Kim et al., 2013). Humidity has no direct significant correlation with the 
several PAHs species properties. However, humidity can be related with other 
parameters like wind speed and rainfall.  Chrysene equivalents (3 benzene rings) and 
BaP equivalents (5 benzene rings) have a positive correlation with wind speed and 
rainfall. Humidity can be a non-direct physical-chemical parameter to promote PAHs 
appearance like BaP and chrysene equivalents. PAHs can occur through different forms 
(volatile and particulate) in different times of the year (winter or summer) that can lead 
to a different deposition type of atmospheric particulate matter (PM). Wet deposition of 
atmospheric PM is carried out by fine particles in the majority of cases. In the 
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environment, the dry depositions of atmospheric PM are more common in PAHs with 
high molecular weight like BaP (Kaupp and Mclachlan, 1999; Zhang, Zhang and Wang, 
2009). The fate of PAHs in the environment can fluctuate thought different factors: 
physicochemical reaction, interactions with other pollutants, PAHs degradation and dry 
and wet deposition (Kim et al., 2013). Most of PAHs are assimilated with other gaseous 
pollutants as SO2, Nox, CO, ozone (Kampa and Castanas, 2008). The gaseous pollutants 
can occur through fossil fuels combustion. Volatile organic compounds (VOCs) are the 
larger part of the gaseous pollutants. In this group are present species of organic 
compounds like PAHs (Kampa and Castanas, 2008).  
Usually, in the environment pollutant mixtures have PAHs metabolites in their 
constitution. They frequent regroup with other PAHs or other xenobiotics depending on 
their composition in the soil, oil in water and sediments or volatile state (Abdel-Shafy 
and Mansour, 2015). PAHs can be more persistent in environment than in human 
tissues. PAHs compounds are ubiquitous contaminants formed in thermal 
decomposition of organic molecules (WHO, 2010; Wang et al., 2013). 
There are several procedures for treating the contaminated soil and usually are a 
combination of an in situ treatment, on-site treatment and bioreactors (Wilson and 
Jones, 1993). The fate of PAHs is determined by soil removal (biodegradation, leaching 
or hydrolysis) and deposition process. The PAHs soil removal process is suitable for the 
2 or 3 benzene rings PAHs mainly with mechanisms of leaching, hydrolysis or 
volatilization (Wilson and Jones, 1993). PAHs with more than 4 rings usually are more 
difficult to remove than the 2 or 3 benzene rings structure compounds. In addition, the 
high molecular weight PAHs are not prone to leaching to underground water and 
usually are available for plants uptake.  The major mechanism of PAHs removal from 
the soil is biodegradation. Biodegradation consists in biological action of 
microorganisms, where bacteria, fungi, and yeasts are able to degrade PAHs (Meire, 
Azeredo and Torres, 2007). This degradation can help remove contaminants from the 
environment. Phytoremediation is other procedure to  reduce or eliminate the abundance 
of PAHs in the environment (Glick, 2003). 
The removal of organic pollutants from the water can occur through several 
processes like destructive oxidation through ozone, hydrogen peroxidase, monogenesis 
oxide, or porous solids. The adsorption technique is used for the removal of 
hydrophobic organic compounds at water the activated carbon, bentonite (Smith and 
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Galan, 1995), fractured chalk (Wefer-Roehl et al. 2001), wood (Boving and Zhang, 
2004) or Leonardite (Zeledón-Toruño et al., 2007).  
Biomonitoring of PAHs in the environment and in human tissues helps to evaluate 
the stage of population contamination and understand the severity of the organic 
compound situation (Glick et al., 2003; Machado et al., 2014). 
1.3 Polycyclic Aromatic Hydrocarbons threshold levels  
 
It is difficult to create a standard PAHs level for tissues because there are several 
studies that use different measurements techniques and unities (Sexton et al., 2011). 
Biomonitoring sediment, water and air can be an useful technique to evaluate PAHs in 
environment and promote the well-being of the humans (Srogi, 2007). Several 
institutions and entities have tried to categorize PAHs due to cases of environmental 
contamination and consequential effects on human health (Conti et al., 2012).  
 Benzo[a]pyrene is used as a marker in food, air as well as in water because of 
the human carcinogenic effects. The inhalation concentration for BaP equivalents 
should not pass 0.032 µg/day because of their carcinogenic characteristic (WHO, 2010). 
U.S. Environmental Protection Agency (EPA) states as maximum air level of 0.1 µg/m3 
for benzo[a]anthracene 0.2 µg/m3, benzo[b]fluoranthene, benzo[k]fluoranthene and 
chrysene. 0.3 µg/m3 for dibenzo[a,h] anthracene and 0.4 µg/m3 for indenol[1,2,3-
c,d]pyrene (WHO, 2010). Most studies reveal inconclusive to determine a maximum 
PAHs level in ambient air. The Directive 2004/107/CE15 of 2004 states a maximum 
BaP equivalents level for the total content in the PM10 fraction averaged over a year of 1 
ng/m3.The American Conference of Government Industrial Hygienists allow 200 µg/m3 
benzene-soluble coal tar pitch fraction for a limit value in the workplace. The American 
National Institute for occupational safety and health has a recommended exposure limit 
of 100 µg/m3 for coal pitch volatile agents in close spaces. Occupational safety and 
health American administration have an exposure limit of 200 µg/m3 of benzene soluble 
coal tar pitch fraction. Major cities in India have a range of 190.96-672 ng/m3 of in the 
air  despite the standard limit of  5 ng/m3 for air (Singh et al., 2008).  
As aforementioned, PAHs could be found in preparation, conservation and 
storage, mostly.  PAHs high concentrations were found in some products like: dried 
fruits, olive pomace oil, smoked fish, grape seed oil, smoked meat products, fresh 
mollusks, spices/sauces and condiments (Table 1-1). FAO/WHO expert Committee on 
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food additives (JECFA) in 2005 projected a risk on PAHs and established margins of 
exposure (MOE) for PAHs as a basis for genotoxic and carcinogenic compounds. The 
margins were established for benz[a]anthracene, benzo[b]fluoranthene, 
benzo[j]fluoranthene, benzo[k]fluoranthene, benzo[g,h,i]perylene, chrysene, 
cyclopenta[c,d]pyrene, dibenz[a,h]anthracene, dibenzo[a,e]pyrene, dibenzo[a,h]- 
pyrene, dibenzo[a,i]pyrene, dibenzo[a,l]pyrene, indeno[1,2,3-cd]pyrene and 5-
methylchrysene. JECFA recommends the Benzo[c]fluorine equivalents analyses. 
Principally in products containing fats and oils, smoking or drying processed foods (fish 
and fishery products) because of the high risk of contamination (UE Directive 
2015/1787 of 2015 ). In the case of mollusks and fish in straight contact with sediments 
or feeding on organisms in contact with sediments, some extra concern may be raised. 
PAHs in sediments may increase in time, due to deposition processes and constitute a 
risk to the environment, but also to humans (Hontela et al., 1992).   
 
Table 1-1- Maximum PAHs levels in different food products according to the EU directive 
2015/1787 from 2015. 
  
Benzo[a]Pyrene (µg/kg) 
ΣPAHs (Benzo[a]Pyrene, 
Benzo[a]anthracene, 
benzo[b]fluoranthene, 
chrysene) (µg/kg)  
Oils and fats  
(except butter and coconut oil) 
2  10  
Cocoa beans and related 
products 
50 (since 2013) 30 (since 2015) 
Coconut oil  
(human consumption) 
2 20 
Smoked meat and related 
products 
2 (since  2014) 12 (since 2014) 
Smoked Sprattus sprattus, 
bivalves (fresh or frozen), fresh 
meat 
5  30  
Smoked bivalves  6  35 
Cereals and related products 1  1 
Infant formulas 1 1 
Diet products  1 1 
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PAHs are classified as priority pollutant in water by the Directive 2008/105/CE of 2008. 
The water suitable for consumption can be other source of PAHs ingestion. According 
to WHO (2010) and IARC (2010) there are PAHs compounds found in water like 
fluoranthene, benzo[a]anthracene, benzo[b]pyrene, benzo[a]pyrene, 
benzo[k]fluoranthene, dibenz[a,h]anthracene, benzo[g,h,i] perylene, indeno[1,2,3-
cd]pyrene. These compounds should not pass a standard level of 0.1µg/L. According to 
Decreto-Lei no 306/2007 of 2007,  the standard level for BaP in water is 0.01 µg/L and 
0.1 µg/L for the total concentration of benzo[b]fluoranthene, benzo[k]fluoranthene, 
benzo[g,h,i]perylene and indeno[1,2,3-c,d]pyrene. In Table 1-2 is presented the 
maximum PAHs levels in inland and other waters according the Directive 2008/105/CE 
of 2008. US EPA classified the 0.2 µg/L as the maximum for benzo[a]pyrene in water. 
Higher concentrations than 0.2 µg/L could be harmful to humans. The major cities in 
India reach levels of PAHs in water up to 65.85 µg/L and the standard limits are 0.2 
µg/L (Singh et al., 2008). 
 
 
Table 1-2- Maximum PAHs levels (µg/L) in water. The analysis was made by AA-EQS and MAC-
EQS (inland and other waters) parameters second Directive 2008/105/CE from 2008. 
 
 
Substance Name 
 
AA-EQS Inland 
surface waters 
(µg/L) 
 
AA-EQS other 
surface waters 
(µg/L) 
 
MAC-EQS 
Inland surface 
waters (µg/L) 
 
MAC-EQS 
other surface 
waters (µg/L) 
Anthracene  0.1 0.1 0.4 0.4 
Benzene 10 8 50 50 
Fluoranthrene  0.1 0.1 1 1 
Naphthalene  2.4 1.2 Not applicable  Not applicable 
Benzo[a]pyrene  0.05 0.05 0.1 0.1 
Benzo[b]fluoranthene 
Benzo[k]fluoranthene 
0.03 0.03 Not applicable Not applicable 
Benzo[g,h,i]perylene 
Indeno[1,2,3-
cd]pyrene 
0.002 0.002 Not applicable Not applicable 
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1.4 Low Molecular Weight PAHs  
 
Low molecular weight PAHs (LPAHs) are compounds with 2 or 3 benzene rings. 
The principal human exposure sources of LPAHs are coal tar, gasoline, diesel fuel, 
paper burning and cigarette smoke (Lai et al., 2011; Kim et al., 2013). This can be 
related with less structurally stable molecules. The photolysis of LPAHs is more 
effective because they are more bioavailable in matrices and have a longer exposure 
time to sunlight. These compounds tend to be in the vapour phase, are highly 
degradable in water and have a low adsorption in sediment (Figure 1-1) (Kim et al., 
2013; Abdel-Shafy and Mansour, 2015). 
 
Figure 1-1 - Representation sources of LPAHs (Naphthalene equivalents with 2 benzene rings and 
phenanthrene equivalents with 3 benzene rings) (Adapted from: American Energy News, 2017; 
Elken, 2017; Healthy preschoolers, 2017; Mariajoaoalmeida, 2017; Sigma-Aldrich, 2017b; Sigma-
Aldrich, 2017c; Time, 2017; Wixstatic, 2017).   
  
 
Naphthalene equivalents are bicycle aromatic hydrocarbons with low molecular 
weight (Kim et al., 2013; Abdel-Shafy and Mansour, 2015). In the human body, 
naphthalene equivalents proceed to hepatic metabolism where they are oxidized to other 
metabolites like alpha-naphtol. Alpha-naphtol is an oxidative metabolite that can lead to 
methemoglobinemia formation and hemoglobin oxidation. Oxidized hemoglobin is 
desaturated with an outcome of Heinz bodies and hemolysis of red blood cells (RBC). 
The hemolysis or methemoglobinemia take place in 1 or 2 days and when reach a peak 
in 3 to 5 days the anemia resulting of RBC hemolysis (Sudakin, Stone and Power, 
2011). In human biomonitoring studies, metabolized naphthalene in 1-
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hydroxynaphthalene and 2-hydroxynaphthalene were observed in the urine of USA and 
Europe adults and children (Preuss, Angerer and Drexler, 2003) . In rhesus macaques it 
was possible to report important information effects of naphthalene in the respiratory 
tract that affect epithelium cells and lungs mainly (Li et al., 2016).  
The National Toxicology Program in the USA (1992-2000) related pulmonary 
alveolar/bronchiolar adenomas induced by cytotoxic effects of naphthalene equivalents 
mechanism in cells. The newborns are more sensitive to naphthalene equivalents 
exposure that adults because of their thinner skin and due to the decrease stores if 
reduced glutathione. Prenatal toxicity can be a result of naphthalene equivalents levels 
cross over the placenta (Sudakin, Stone and Power, 2011). Madhavan and Naidu (1995) 
related a possible LPAHs species transaction from the mother to the fetus as PAHs 
residual levels detected in human placenta, umbilical cord blood, maternal blood and 
human milk. In Shengsi Islands, the highest PAHs concentrations found in umbilical 
cord serum from 120 mothers and newborn pairs were of naphthalene equivalents (of 
the 16 PAHs species analyzed). These compounds are classified as possible 
carcinogenic by EPA, mutagenic and teratogenic to humans (Sudakin, Stone and Power, 
2011) . The International Agency for Research on Cancer (IARC, 2010) classifies in 
terms of effects the different PAHs species in 4 groups. (1) 119 PAHs are considered 
carcinogenic to humans; (2a) 81 PAHs are “Probably” carcinogenic to humans; (2b) 
292 PAHs species are “Possible” carcinogenic to humans; (3) 505 species are not 
possible to classify 505 PAHs species; (4) Just 1 PAHs species is “Probably” not 
carcinogenic to human. Naphthalene equivalents is a “possible” carcinogenic to human. 
Additionally to this classification, Farhadian et al. (2012) created some important key 
points of PAHs classification in groups to add as those described by IARC. In a first 
approach it is important to investigate the kinetics, PAHs formation and mechanism of 
mutagenic/carcinogenic/teratogenic activities, followed by PAHs examination in food 
and biomonitoring human exposure to PAHs.  
Naphthalene equivalents are present in the environment in tobacco smoke, coal 
tar and mothballs (Kim et al., 2013; Sudakin, Stone and Power, 2011). Mothballs are 
99.9% naphthalene equivalents and the weight can fluctuate from 0.5g to 5g. However, 
they are usually sold in 396 g cases and can release 200 µg/m3 in an 1-year period. 
National Pesticide Information Center in the USA in 2006 had 769 reports of 
naphthalene equivalents exposure incidents. 60% of the cases were associated with 
misapplication of the compound. Color and ball shape can induce a wrong perception in 
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small children because it is usually mistaken for a toy ball. These can lead to some cases 
of naphthalene equivalents ingestion (Sudakin, Stone and Power, 2011).  
In an investigation regarding urban, rural and intermediate place of residence in 
France was possible to observe high concentration were of low molecular weight PAHs. 
The highest concentration found was of naphthalene equivalents with 53.7 ng/m3 and 
phenanthrene equivalents with 26.2 ng/m3 (Annamalai and Namasivayam, 2015). 
Phenanthrene equivalents arise from biomass, wood combustion, and food such as meat, 
fruit, dairy products, oils, and fats. Concentrations in these products ingested by humans 
can be up to 18.18µg / kg phenanthrene equivalents (Martorell et al., 2010; Mohanraj, 
Dhanakumar and Solaraj, 2012). There are other sources like pesticides and resins 
formation (Kim et al., 2013; Abdel-Shafy and Mansour, 2015). Phenanthrene 
equivalents have slow photolysis degradation because of the molecular stability of this 
compound. In the atmosphere phenanthrene equivalents tend to form a molecular 
complex (Abdel-Shafy and Mansour, 2015). 
Phenanthrene and anthracene equivalents are the smaller PAHs types classified as 
“possible non-carcinogenic” polycyclic aromatic hydrocarbons by IARC (IARC, 2010). 
Jung et al. (2013) study present a several PAHs concentrations exposure - including 
phenanthrene equivalents - to rat’s liver. That exposure result in transcriptomic changes 
in rat’s liver tissue. More studies are necessary to clarify genotoxic effects of 
phenanthrene equivalents in human tissues (Kim et al., 2013).  
Phenanthrene-type PAHs have higher concentrations in winter and urban areas 
(Mohanraj, Dhanakumar and Solaraj, 2012). It is possible that phenanthrene equivalents 
cause teratogenic effects (Kim et al., 2013). It was measured PAHs species in placenta 
of children with neural tube defect and children without neural tube defect. The children 
with neural tube defects had higher phenanthrene and fluorene equivalents levels than 
the children without the neural tube defects (Ren et al., 2011). Both of these species 
have three benzene rings (Kim et al., 2013).  
 
1.5  High Molecular Weight PAHs  
 
The HPAHs have a low vapour pressure, less aqueous solubility and less photo-
sensitivity than LPAHs. Because of HPAHs stability, most species are found in the 
particulate phase. It is possible to found these PAHs in the environment due to natural 
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and anthropogenic sources. Natural sources include volcano and forest fires, whereas 
anthropogenic sources include commercial and industrial combustion, road transport 
and metal production (Figure 1-2) (Zhang, Zhang and Wang, 2009; Kim et al., 2013). 
 
Figure 1-2 - Representation sources of High molecular weight polycyclic aromatic hydrocarbons 
(Pyrene equivalents with 4 benzene rings and benzo[a]pyrene equivalents with 5 benzene rings) 
(Adapted from: Amazon, 2017; Cduarouca, 2017; Global Transport Knowledge Practice, 2017; 
Mundo educação, 2017; Organizar a casa,  2017; Sigma-Aldrich, 2017a; Sigma-Aldrich, 2017d; 
Scheererbearing, 2017; Skillplus, 2017; Time, 2017). 
 
Pyrene equivalents are high molecular weight compounds with four benzene 
rings and classified as non-carcinogenic to human (IARC, 2010). Generally, pyrene 
equivalents enter the human body by ingestion. In Shengsi Islands (China), the majority 
of ingested protein is obtained through aquatic products (Yin et al., 2016). Umbilical 
cord serum samples collected from parturient living in the East China Sea presented 
high levels of pyrene equivalents. Feeding choices (fish consumption) can be a source 
of human contamination by pyrene equivalents. Yin and co-authors (2016) found a 
possible correlation between pyrene equivalents and reproductive hormones like 
estrogens’ hormones. The PAHs exposure negatively affects -estradiol (E2) and 
positively affects FSH in umbilical cord blood. So, it is possible that PAHs as pyrene 
equivalents act as a type of endocrine disruptor chemical (EDC).   
Benzo[a]pyrene or BaP equivalents are compounds composed by five benzene 
rings, considered large size PAHs and usually is found in environment adsorbed to 
particulate phase xenobiotics. BaP equivalents are metabolized in human organism. In 
metabolization phase, nonpolar PAHs are transformed into phenols and diols. Phenols 
and diols bind to DNA forming PAH-DNA adducts. This binding promotes genetic 
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mutations and can be associated with different cancer types (Kim et al., 2013; Machado 
et al., 2014). The p53 protein mutation can be related to the skin and lung cancer. These 
mutations are caused by xenobiotics such as BaP equivalents (Abdel-Shafy and 
Mansour, 2015). 
Still considering long term effects, BaP equivalents can be considered was the first 
studied specie of PAHs that had carcinogenic, genotoxic and teratogenic effects in 
human (Abdel-Shafy and Mansour, 2015). 1-Hidroxypyrene and BaP equivalents were 
found in the urine of smoker and passive smoker parturient. These BaP equivalents and 
1-hydroxypyrene have a positive correlation with cotinine found in parturient. This 
correlation can be an explanation to neuroteratogenic effects like brain damage, 
cognitive problems, emotional and behavioural effects in newborns and children 
(Machado et al., 2014). Low birth weight, premature delivery, heart malformations are 
some of the birth outcomes related to PAHs exposure. EPA and IARC describe BaP 
equivalents a human carcinogenic (IARC, 2010; Kim et al., 2013; Machado et al., 
2014). In contact with the skin in a short term effect, BaP equivalents are a skin irritant. 
Most of the BaP equivalents exposures are related to tobacco smoke but there are other 
sources like vehicle exhaust, barbecued, roasted, fried and smoked meat and industrials 
smoke (Choi et al., 2012; Jedrychowski et al., 2013; Kim et al., 2013; Abdel-Shafy and 
Mansour, 2015). 
1.6  Kinetics of PAHs in the human organism  
 
There are several ways of PAHs adsorption on the body. Different PAHs species 
have different modes of action and can bioaccumulate in diverse organs. Usually, PAHs 
concentrations are higher in the liver because of his filtration and detoxification 
functions (Meire, Azeredo and Torres, 2007; Sexton et al., 2011 and Kim et al., 2013).  
Inhaled PAHs can be adsorbed by bronchial epithelial cells, skin cells and intestine 
cells. PAHs stay in ciliated mucus or penetrate through bronchial epithelium cells where 
they are metabolized. The absorption occurs also in other pathways, like ingestion and 
skin absorption (Meire, Azeredo and Torres, 2007; WHO, 2010; Kim et al., 2013). 
PAHs distribution through the body can be fast. Most PAHs species are lipophilic. This 
characteristic allows PAHs to have an easy passage through biologic membranes 
(WHO, 2010). Factors like age, gender, body fat percentage, metabolism of xenobiotics, 
physical characteristics (body mass index) and lifestyle (smoking, alcohol consumption, 
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physical activity) can influence the PAHs metabolism. The excretion can occur through 
urine or faeces. Species of LPAHs are excreted via urine mostly and high molecular 
weight PAHs species can be excreted via feces. However, there are PAHs that 
accumulate in the body (Urbancova et al., 2017). 
Biotransformation is a process where the conversion of a xenobiotic into other 
compounds occurs inside organisms. PAHs biotransformation process is based on the 
lipophilic metabolite transformation in a hydrophilic metabolite. Transformation main 
goal is to make an easier excretion of the metabolites. PAHs biotransformation in phase 
I oxidation metabolism by CYP450 (cytochrome P450 family) monooxygenases to 
reactive epoxide intermediates followed by reduction or hydrolyzes like urinary PAHs 
metabolites (OH-PAHs). In phase II metabolism, a conjunction reaction of OH-PAHs 
with glucuronic acid or sulphate occurs to enhance water solubility (Choi et al., 2012). 
The induction of CYP (cytochrome) from de Ah receptors is related with the 
PAHs excretion. In PAHs metabolism there are two types of key enzymes/groups: 
cytochrome P450 family and epoxide hydrolase. In the cytochrome P450 family the 
CYP1A1, CYP1A2, and CYP1B1 are the key enzymes more produced to metabolize 
PAHs. There are three principal mechanisms on activation of PAHs for toxic 
intermediates in metabolism: 
 The most common (dihydro)diol-epoxides formation through enzymatic 
oxidation reactions resulting in hydrolysis; 
 Via radical cation formation; 
 O-quinone pathway. The CYPs metabolize PAHs in several Quinones (Meire, 
Azeredo and Torres, 2007; WHO, 2010; Choi et al., 2012). 
There are PAHs capable of binding with macromolecules (proteins and nucleic acid) 
and before phase I became reactive metabolites causing damage. This damage might 
include: 
 Mutagenic effects: DNA adduct formation blocks DNA from replicate and 
induces base and nucleotide excision repair activities. These repair activities can 
induce errors in DNA replication. These miscalculations can be fixed mutations 
after cell division. Pathological abnormalities (leiomyomas) in vagina, cervix, 
and uterus are related with mutagenic effects in mammal species (Annamalai 
and Namasivayam, 2015; Abdel-Shafy and Mansour, 2015);  
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 Carcinogenic effects: some alterations in DNA can lead to lack of control of cell 
formation that leads to the formation of cancers like adrenal and thyroid tumors 
and mammary adenocarcinomas (Abdel-Shafy and Mansour, 2015; Annamalai 
and Namasivayam, 2015);   
 Teratogenic effects: PAHs teratogenic effects like low birth weight, premature 
delivery and heart malformations of the fetus can be connected with a possible 
human exposure (Abdel-Shafy and Mansour, 2015).  
1.7  Challenges in PAHs chemical analysis 
 
Several studies try to create a best way for PAHs chemical analysis. The fixed 
wavelength fluorescence (FF) measurement technique refinement can generate a 
premium methodology with some important characteristics like low cost, high number 
of samples analysis in a short time period, a sensitive method and easy to understand by 
the user. Usually for PAHs measurement is used gas chromatography-mass 
spectrometry (GC-MS) (Sexton et al., 2011; Yu et al., 2011), high performance liquid 
chromatography (HPLC) with fluorescence detection (Singh et al., 2008; Chen et al., 
2014; Machado et al., 2014), synchronous fluorescence spectroscopy (SFS) and fixed 
wavelength fluorescence (FF) (Aas et al., 2000).  
Gas chromatography-mass spectrometry is an analytical method used in the 
detection of several volatile and semi-volatile organic compounds. Some detections of 
GC-MS technique are:  
 Quantification and identification of volatile or semi-volatile PAHs in mixtures 
of several compounds and;  
 Molecular weight, structural determination and possible composition of 
unknown PAHs (Hites, 1997). 
EPA uses GC-MS techniques to quantify the pollution of the drinking water and 
waste water. Other entities in the field of pharmaceutical or forensic sciences use GC-
MS for PAHs and drugs determination in blood or urine.  In food industry it is used for 
the product quality control.  GC-MS jet separator is one important commercial GC 
carrier gas separator that takes advantages of the differences in diffusibility among the 
carrier gas and the organic compound (like PAHs). Usually, the carrier gas has high 
diffusion coefficient and the organic pollutants have a lower diffusion coefficient. The 
carrier gas is sprayed over a wide solid angle and the high molecular weight PAHs are 
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sprayed in a much narrower angle and go straight to vacuum region. It is collected the 
middle section of a solid angle with a skimmer. This section is passed in to a mass 
spectrometer and PAHs with high molecular weight are separated from the carrier gas 
that is removed from a vacuum pump. The major limitation of GC-MS methodology is 
that only compounds exceeding 10-10 torr of vapour pressure are analyzed. This fact 
restrict the qualitative accuracy (Hites, 1997).  
Chromatography is a separation method with sensitive detection that allows micro 
quantities analysis of complex matrices material (Lingeman et al., 1985). HPLC was 
developed for clinical, pharmaceutical, environmental and food analysis (Gámiz-Gracia 
et al., 2009). Adsorption onto surfaces, partition coefficients in systems of two non-
homogeneous mixtures, ionic solutes interactions with ion-exchanges site surface or 
molecular size are the principal characteristics of the liquid chromatography analysis. 
The quantum yield of fluorescence of these chemicals is frequently low in polar 
solvents, which is the principal disadvantage of this methodology. The HPLC detection 
occurs in a fluorimeter equipped with a flow cell (on-line detection) or fixed wavelength 
fluorescence (FF) (off-line detection). The selection of fixed fluorescence wavelength 
the fluorimeter, filters or monochromators are essential for the sample analysis.  
Excitation and emission radiation intensity have a higher sensitivity with filters. The 
monochromator promotes enhancement and selectivity of PAHs detection in urine or 
serum samples better than filters (Lingeman et al., 1985).  
The fluorescence measurements are performed by an excitation spectrum. That 
excitation spectrum is achieved by scanning the excitation monochromator while setting 
the emission monochromator at an optical wavelength. An emission spectrum 
monochromator set at an appropriate single-excitation wavelength (Li et al., 2011). Two 
polarization filters (excitation/emission) are necessary for anisotropy measurements. 
The monochromator can be adjusted to the wavelength selected. Spectrofluorimeters 
apply diffraction grating monochromators for the incident and fluorescent light 
incitation. Filter fluorimeters make use of filters to isolate light. Spectrofluorimeters and 
fluorimeters follow the same scheme for detecting the sample fluorescence. The light 
(LED, laser or lamp) came from an excitation source and passes through a filter or a 
monochromator to hit the sample. Photons influence on the excitation monochromator 
witch discriminatively transmits light in a confine range focusing in the specified 
excitation wavelength. The transmitted light cross adjustable slits that regulate 
magnitude and resolution by restrict the range of transmitted light. The filtrated light 
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goes into the cell of the sample creating fluorescence emission by fluorophores within 
the sample. The fluorescence is measured at a 90º angle in order to not take place 
interference. Emitted light passes in a confine range centred above the wavelength and 
gets out through adjustable slits and lastly enters the photomultiplier tube (PMT). The 
amplifier signal forms a voltage that is proportional to the emitted intensity 
measurement. Could occur some noise derived from PMT. The detector can be single 
channelled or multichannel. Single channelled measures one wavelength and multi-
channel measures several wavelengths at one time (Al-Rawashdeh, 2012).  
SFS (Synchronous fluorescence spectroscopic) is the technique low cost and simpler 
than HPLC. SFS is obtained by the scan of both excitation/ emission monochromators 
simultaneously (Lin, Cormier and Torsella, 1996; Li et al., 2011). Vo-Dinh (1978) 
define some principal characteristics of this technique: (1) Confine spectral bands that 
stem from the multiplication of two increasing and/or decreasing functions, 
simultaneously; (2) Emission spectra’s simplification considering that conventional 
fixed spectrofluorimetry and only it is possible to rise the intensity of all of the emission 
bands at some time, the synchronous technique enable the higher peaks to be rise 
selectively by use of a suitable wavelength; (3) Reduction of the spectral range. An 
analytical point of view all spectrum are not interesting and some details may not be 
considered. 
Fixed wavelength fluorescence (FF) detection is a simpler method, allows 
measuring PAHs exposure on a large number of samples and at a lower cost than HPLC 
and GC-MS techniques. It is a highly sensitive technique and it is possible to obtain 
positive results with low quantities of sample. These advantages make this technique 
suitable for clinical analyses (Aas et al., 2000). This technique was used in this thesis 
and in other studies (e.g. Gravato and Santos, 2003). In order to understand if crude oil 
was bioaccumulated in cod fish was used fixed wavelength fluorescence (FF) 
measurements to determine PAHs concentrations in bile samples (Aas, Beyer and 
Goksøyr, 2000). Oliva et al. (2010) covered a larger PAHs concentration range in order 
to collect bigger information about the PAHs concentrations in Solea senegalensis liver 
samples.  
The major disadvantage of fixed wavelength fluorescence and synchronous 
fluorescence spectrometry can be considered overlapping problems. Overlap can 
confuse the results in the presence of all spectrums and the emission of other PAHs in 
samples. The resolution of the mixture spectra it is possible to overcome but is very 
 time consuming and the equipment that is used for that aim is very expensive. So, in 
order to overstep the problem other techniques have been developed as the combination 
of synchronous fluorescence spectrometry with chemometrics or using DMSO as a 
solvent in PAHs measurement
spectra suppressing the background noise and band
that it is measured. In F
phenanthrene, pyrene and 
possible overlap (Li et al., 2011).   
 
Figure 1-3 - Naphthalene (green) Phenanthrene (blue), 
Wavelength (nm) representation. The 
represent the excitation wavelength
 
1.8 Human matrices as biomarkers of exposure to PAHs
 
Human health can be influenced by life style factors that include medication, smoke, 
drug abuse, alcohol consumption and environmental sources. Xenobiotics enter the 
body and bioaccumulate in different organs because of the different metabolization 
processes associated. Organs, tissues and cell biomonitorization can be used to measure 
the target chemicals. It is important to establish detection limits for corresponding 
organs, tissues or cell analyses for the different analytical techniques 
Pasanen and Pelkonen, 2005
analyzed can provide information about several persistent organic pollutants
3). Some studies revealed that PAHs are able to cross from mother to fetus thought the 
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. The DMSO reduces the interferences of the different 
-narrowing the specific 
igure 1-3 it is possible to observe how naphthalene, 
BaP equivalents were localized in the spectrum and the 
 
Pyrene (pink) and Benzo
lighter lines are the emission wavelength, the darker lines 
 (Adapted from Li et al., 2011).  
  
; Esteban and Castaño, 2009) . Different human matrices 
 
PAHs -type 
 
[a]pyrene (red) 
(Myllynen, 
 (Table 1-
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placenta barrier (Madhavan and Naidu, 1995; Sexton et al., 2011; Machado et al., 2014; 
Urbancova et al., 2017). 
 
Table 1-3 - Range of mean concentration of TPAHs or Phenanthrene, Pyrene, 
Benzo[b]fluoranthene, 1-hydroxypyrene and BaP in biological samples from world population. 
COUNTRY TISSUES MEASUREMENT PAH MEAN(SD) REFERENCE 
China 
(Shengsi 
Islands) 
 
Umbilical cord 
serum  
GC 
analysis 
TPAH*1*2 218.36(173.84)ng/mL Yin et al., 
2016 
China 
(Hong 
Kong) 
(1) Maternal 
Serum  
(2)Umbilical 
cord serum  
HPLC Pyrene  (1)163.24±145.22 
ng/mL 
(2)103.88±93.28ng/mL 
Chen et al., 
2014 
USA 
(Texas) 
(1) Cord blood 
(2)Maternal 
blood 
GC-MS TPAH*1*3 (1) 12.8 ng/mL 
(2)5.5ng/mL 
Sexton et 
al., 2011 
Brazil 
(Porto 
Alegre) 
(1) Urine 
(2)Amniotic 
fluid 
(3)Umbilical 
cord blood 
HPLC 1 e 2- 1-
hydroxypyrene 
3-BaP  
(1) 0.15 (9.63) ng/mL 
(2)0.67(1.39) ng/mL 
(3)1.13 (1.99) ng/mL  
Machado et 
al., 2014 
China 
(Beijing) 
Placenta 
 
GC-MS 
 
TPAH*5 
 
9.30(575)ng/g fat 
 
Yu et al., 
2011 
 
USA 
(New York) 
Placenta GC-MS Benzo[a]pyrene 2.37 ng/g Perera et al., 
2009 
India 
(Lucknow) 
Placenta HPLC Benzo[b] 
fluoranthene 
Median (250.27µg/g) Singht et al., 
2008 
Ukraine 
( Kyiv and 
Dniprodzerzh
insk) 
Placenta   PAH*6 Median (7.36 µg/g) Gladen et 
al., 2000 
Poland 
(Lodz and 
Legnica 
districts) 
Urine  GC-MS (1) Phenanthrene  
(2)Pyrene  
(1) 3050(2580)ng/mL 
(2)770(600)ng/mL 
Polanska et 
al., 2014 
Czech 
Republic 
(Karvina 
and Ceske 
Budejovice) 
Urine U-HPLC T OH-PAHs *4 5.3 ng/mL Urbancova 
et al., 2017 
 
*1 Naphetalene, Acenaphtene, Anatracene , Phenanthrene, Fluorine, fluoranthene, pyrene, 
*2 Biphenyl, Dibenzofluorane, Dibenzothiophene.  
*Acenaphthylene, benzo[a]anthrancene, chrysene, benzo[b]fluoranthene, Benzo[k]fluoranthene, benzo[a]pyrene, indeno[1,2,3-
c,d]pyrene, dibenzo[a,h]anthracene and Benzo[g,h,i]perylene.  
*4 naphthalene-1-ol, phenanthrene-1-ol, pyrene-1-ol, fluorine-1-ol; naphthalene-2-ol, phenanthrene-2-ol, phenanthrene-3-ol, 
phenanthrene-4-ol, benzo[a]pyrene-3-ol; crysene.4-ol; benzo[a]pyrene-7-ol. 
*5 Acenaphthylene, benzo[a]anthrancene, chrysene, benzo[b]fluoranthene, benzo[a]pyrene, indeno[1,2,3-c,d]pyrene, 
dibenzo[a,h]anthracene and Benzo[g,h,i]perylene , Acenaphtene, Anatracene , Phenanthrene, Fluorine, fluoranthene, pyrene.  
*6 Chrysene, benzo[b]fluoranthene, benzo[a]anthrancene, benzo[a]pyrene, indeno[1,2,3-c,d]pyrene, dibenzo[a,h]anthracene and 
Benzo[g,h,i]perylene 
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The matrices are expelled from the body, so it is not necessary to damage or 
invade the physical interagency to collect them. However, human milk, placenta, 
umbilical cord, placenta membrane, urine and even blood are examples of excretions, 
tissues, organs and membranes used as biomarkers of exposure biomonitorization 
studies related with PAHs contamination, accumulation and excretion in humans. These 
are the most used because of their non-invasive characteristics (Esteban and Castaño, 
2009; Sexton et al., 2011; Yu et al., 2011; Machado et al., 2014).  Non-invasive 
samples are gathered outside the body so; the organism integrity is not invaded or 
destroyed. Blood can be classified as non-invasive matrix when removed from 
umbilical cord or as invasive matrix when it is taken by the mother blood vessels 
(Esteban and Castaño, 2009) (Figure 1-4). 
 
Figure 1-4 - Invasive (intravenous) and non-invasive (umbilical cord) blood collect. Separation 
blood cells from plasma (Adapted from: Awebic, 2017; Clipartpanda, 2017; Clker, 2017; 
Culturamix, 2017). 
 
Samples collected from humans are donated to the science by the owner. All the 
ethical issues must be discussed and analyzed in order to cause effects no impairment in 
human health (psychologically and physically). Blood is a tissue that contacts with all 
organs inside the organisms and is used regularly in toxicology studies (Esteban and 
Castaño, 2009).  
1.8.1 Placenta as a biomarker of PAHs exposure 
 
 In human toxicology studies, placenta can be used as a matrix after expelled in 
during parturition. Placenta was already used as an efficient matrix for 
biomonitorization of metals (Hg), POPs and organo-chlorine pesticides in prenatal 
exposure (Vizcaino et al., 2014; Alves et al., 2017; Jeong et al., 2018). Some studies 
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suggest that is possible to determine newborn future diseases by analyzing the placenta 
(Andraweera et al., 2015).  
The placental unit is composed by trophoblastic and fetal epithelial cells. The 
mature placenta develops different components that are characterized as chorionic plate, 
chorionic vili, decidua basalis and umbilical cord (Figure 1-5) (Cross et al., 2003).  
 
 
Figure 1-5 - Placenta representation (Cross et al., 2003). 
 
Placenta is involved in fetal growth, development, nutrient transfer and products 
excretion thought the intervillous space. However, it is important to recognize other 
functionalities of placenta like metabolic and endocrine functions (Bauer et al., 1998).  
Xenobiotics can interfere with functions of placenta like signalling, hormonal effects, 
transport function, cell growth, maturation and delivery.  Xenobiotics bioaccumulation 
can lead to preterm delivery, fetus weight alterations and in the worst case scenario 
malformations and fetus abortion (Myllynen, Pasanen and Pelkonen, 2005). 
 Nutrients’ transfer and excretion between mother and fetus involves passive 
diffusion transfer of O2 from the mother to the fetus and the excretion of CO2 and urea 
from the fetus to the mothers’ body. Facilitated diffusion mediates glucose and lactate 
transfer (Bauer et al., 1998). In this process, active transport with energy costs make 
amino acids pass through the membranes. In addition, pinocytosis, a transference 
mechanism based on the invagination of compounds (mostly drugs) through the 
membrane cell and aquaporins are water channel proteins that relocate water, mostly 
(Bauer et al., 1998; Barr, Bishop and Needham, 2007; Sha et al., 2011). Some toxins 
like nicotine and cocaine are transported like amino acids. In active transport, 
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exogenous compounds change placenta transfer of endogenous compounds. This 
interference with transporters can be adverse to fetal devolvement and damage in 
placenta functions (Myllynen, Pasanen and Pelkonen, 2005). Xenobiotics cross the 
placenta by simple passive diffusion or linked to proteins that pass through biological 
membranes. Xenobiotics enter to placenta through 20 different proteins, approximately. 
On the other side there are also some proteins that have the ability to prevent the entry 
of xenobiotics. The most well-known one is P-glicoprotein or the MDR1 gene product. 
P-glicoprotein has the ability to pump the substrates from intracellular to extracellular 
compartments. This protein was found in human placenta trophoblasts from first 
semester pregnancy to the baby delivery. It has a protection function in order to prevent 
teratogenic effects and fetal toxicity. Others like MRPs 1 to 5 (multi drugs resistance 
associated proteins) and BCRP (breast cancer resistance proteins) were found in the 
human mRNA from the first trimester pregnancy to the delivery (Myllynen, Pasanen 
and Pelkonen, 2005). Depending on the PAHs type, they enter the placenta through 
several processes like facilitated diffusion, passive diffusion, active transport and 
filtration (Sexton et al., 2011). Persistent compounds like PAHs can enter the hepatic 
blood stream circulation because of their lipophilic characteristic. They can continue in 
the fetal environment because they may be deposited and /or continue circulating in the 
hepatic blood stream. This way, through the umbilical cord and/or the umbilical cord 
blood, it is possible to understand if these compounds are in the fetal organism, so can 
be classified as a biomarker of exposure for the fetus too (Barr et al., 2007). 
The pregnancy state is characterized by a higher oxidative stress in the mother 
and fetus. Placental mitochondrial activity induces oxidative stress, rise of ROS 
production (mainly the superoxide radical) and reduced scavenging function of 
antioxidants. The process of oxidation stress is characterized by an oxygen gradient 
between fetus and mother and it is affected by the higher ROS production in the mother 
circulation. ROS levels alterations during pregnancy state are important to assure 
normal growth of embryos and fetus (Myatt and Cui, 2004). The early post-implantation 
period is the most sensitive time to oxidative stress for the embryo. The uterus is 
hypoxic, in order to help the induction of proliferation of cells. Later on the fetus 
development the rise of oxidative stress can lead to differentiation and ROS act like a 
messenger for regulate transcription factors that could affect gene expression in embryo. 
During pregnancy the excessive increase of oxidative stress can be associated with 
miscarriage and other complications like pre-eclampsia, diabetes and intrauterine 
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growth retardation (Rossner Jr et al., 2009). One of the main functions of the placenta is 
promoting oxygen supply to the fetus. Lack of oxygen availability can lead to acute and 
chronic hypoxia (Macklin et al., 2017). Regulators of trophoblast, proliferation, and 
differentiation can lead to oxygen tension. Xenobiotics can damage regulation of 
cytotrophoblast, proliferation and differentiation can result in alterations of placental 
responses to oxygen tension (Myllynen, Pasanen and Pelkonen, 2005) 
Once absorbed, PAHs can enter the lymph, circulate in all body through the 
blood and are primarily metabolized by the liver and kidneys (Kumar et al., 2014).  
They usually can bioaccumulate and be found in breast milk or adipose tissue because 
of is lipophilic characteristics and are excreted through urine or bile after being 
enzymatic metabolized into polar metabolites by responsible enzymes. In blood, PAHs 
have a half-life relatively short as it is a passage matrix. The PAHs concentrations in 
placenta usually are higher than PAHs concentrations in blood (Machado et al., 2014). 
Placenta is an organ that has the ability to bioaccumulate PAHs. At the end of the 1st 
trimester, the food intakes by the mother increases due to the higher levels of 
progesterone and hPL (human placental lactogen), while the metabolic demands are 
very low in mothers’ body. This results in an increasing of fat that represents a loss of 
the normal homeostatic mechanism and regulate the energy balance (Burton and 
Fowden, 2015). The lipophilic characteristics of the fat perform as adsorption factor for 
PAHs species (Kumar et al., 2014). In placenta PAHs can be metabolized, being this 
organ referred often as an excretion route for PAHs due to the residence time of 9 
months.  There are other excretion routes in human body like milk, urine or feces 
(Kumar et al., 2014).  
Biomarkers of exposure used in epidemiological studies are usually based on 
blood, urine or feces. There are positive and negative points in using placenta as a 
matrix for measurements of biomarkers of exposure. The collection and handling are the 
principal reasons to not use placenta as a matrix (Iyengar and Rapp, 2001), while the 
principal positive points are related to its big size, where one sample can be used to 
carry out several analytical measurements (chemical or biological) and it is considered a 
non-invasive matrix. Regarding PAHs, several compounds have been quantified in 
human placenta (Dejmek et al., 2000;  Kampa and Castaño, 2009; Sexton et al., 2011; 
Yu et al., 2011; Chen et al., 2014; Machado et al., 2014; Tang et al., 2014; Yin et al., 
2016; Urbancova et al., 2017).  
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1.8.2 Blood as a biomarker of PAHs exposure 
 
In vertebrates, blood is a liquid conjunctive tissue formed by cells and plasma 
which circulates in a closed vascular system (capillary tubes). Blood cells can be 
categorized in red blood cells (RBC), white blood cells (WBC) and platelets. Blood 
main functions include transportation (nutrients, hormones, O2 and CO2), protection 
(leukocytes, antibodies and platelets) and regulation (pH and water balance). Blood 
circulates through all body, so it is possible to obtain general information on all tissues 
and organs. Several studies make use of samples of parturient and umbilical cord blood. 
The blood matrix is usually analyzed divided into plasma and blood cells or just as 
homogenized blood (Esteban and Castaño, 2009; Yu et al., 2011; Annamalai and 
Namasivayam, 2015).  
EPA considers blood one of the best matrices for xenobiotics analyses (Madvan 
and Naidu, 1995). Blood extraction can be considered an invasive procedure, with some 
limitations considering the quantities required for analysis, being therefore needed to be 
collected in a way not to cause damage or considered harmful to humans (Esteban and 
Castaño, 2009). Blood can be used as a matrix to measure xenobiotic exposure from 
mother and baby. Significant concentrations of bisphenol A (BPA) were correlated with 
human umbilical cord blood. BPA concentrations can be related with some behavioral 
and mental problems in children (mostly until 42 months). Gender difference can be 
related with the alterations in the BPA metabolization (Minatoya et al., 2017). PFA 
(perfluoroalkyl substances) concentration measurements were collect from umbilical 
cord blood. The children were followed in this study until the 108 months and some 
correlations were detected with liver problems, thyroid problems, possible tumor 
formation, neural and growth problems. Different problems related with the children’s 
gender can also occur (Chen et al., 2017).  
Yu et al. (2011) performed PAHs measurement in placenta, umbilical cord blood 
and human milk. Umbilical cord blood presented the highest PAHs concentration of low 
molecular weight PAHs and the lowest concentration of high molecular weight PAHs. 
Madhavan and Naidu (1995) found a higher concentration of PAHs in umbilical cord 
compared with the maternal blood. This fact can be connected with the lipids and 
lipoproteins concentrations at higher quantities in the umbilical cord plasma (Sexton et 
al., 2011; Chen et al., 2014). The PAHs present in umbilical cord blood are correlated 
with cotinine concentrations and total PAHs levels were higher in smoker than in non-
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smoker parturient. There were no significant differences between non-smoker parturient 
women and passive smoker parturient women (Machado et al., 2014). Most PAHs 
compounds have a half-life of 18 hour in the organism (Sexton et al., 2011; Machado et 
al., 2014).  
1.9 Motivation, objectives and dissertation layout 
 
Humans are exposed to chemical contamination through different sources, via 
inhalation, ingestion or dermic. These exposures are related directly or indirectly with 
environmental contamination but also with daily habits (e.g. smoking). The panoply of 
chemical compounds to which humans are exposed are enormous, going from 
pharmaceuticals, to metals, pesticides (e.g. organochlorides, carbamates), PAHs, 
amongst others (Kim et al., 2013). 
In the present dissertation, PAHs were chosen as model chemicals to study human 
exposure. PAHs are persistent organic pollutants that have in their constitution 
hydrogen, carbon and benzene rings (Kim et al., 2013; Jeong et al., 2018). The number 
of benzene rings can fluctuate and originate different chemical species, varying from 
two (naphthalene equivalents) or three (phenanthrene equivalents) rings, and being 
classified as low molecular weight PAHs, to four (pyrene equivalents), five (BaP 
equivalents), six (Benzo[ghi]-perylene equivalents) or seven rings (indeno[1,2,3-cd] 
pyrene equivalents), classified as high molecular weight PAHs. They have some 
characteristics and different ways of adsorption in human body, which are associated 
with the number of benzene rings present (Kim et al., 2013). The identification, 
quantification and determination of PAHs in human samples are essential for an 
understanding of mechanisms, human health risk and PAHs related diseases (Figure 1-
6) (Li et al., 2011).  
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Figure 1-6 - LPAHs and HPAHs main sources and potential effects on human health (Adapted 
from Kim et al., 2013; Li et al., 2016). 
There are several studies that measured PAHs levels in non-invasive human 
tissues (Sexton et al., 2011; Mohanraj, Dhanakumar and Solaraj, 2012; Tang et al., 
2014; Yin et al., 2016). In Portugal, PAHs exposure has been quantified in food 
(Teixeira, Casal and Oliveira, 2007; Yebra-Pimentel et al., 2014), air (Slezakova et al., 
2011; Albuquerque, Coutinho and Borrego, 2016) and sediments (Martins, Ferreira and 
Vale, 2008). Considering these exposure scenarios, some studies have already looked at 
PAHs concentrations in biological matrices as biomarkers of human exposure. The 
determination of PAHs levels in human urine (Oliveira et al., 2017) from 108 fire 
fighters from Vinhais, Mirandela and Bragança (north of Portugal) was carried out and 
urinary PAHs metabolites (OH-PAH) levels in firefighters that have been exposed to 
fire smoke were higher in those who smoke than in non-smoker firefighters (Oliveira et 
al., 2017).  
 In Aveiro region the principal PAHs source of emissions can be considered oil, 
industrial or domestics spills in Ria de Aveiro, vehicles emissions and burning smoke. 
Indication of exposure to these emissions are reported by the measurements of different 
PAHs species like naphthalene, acenaphthalene, acenaphthylene, fluorene, 
phenanthrene, anthracene, fluoranthene, pyrene, benzo[a]anthracene, chrysene, 
benzo[b]fluoranthene, benzo[k]fluoranthene, benzo[a]pyrene, benzo[g,h,i]perylene, 
dibenzo[a,h]anthracene and indeno[1,2,3- c,d]pyrene equivalents in eggs from different 
bird species in Aveiro region (Pegas et al., 2012) suggests an higher average values that 
Natural sources: Forest Fires 
and Volcanic eruptions 
Anthropogenic sources: 
Industrial combustion and metal 
production. 
Mainly anthropogenic sources: Coal 
tar, Gasoline and cigarette smoke  
PAHs health effects:  
 short term :eye and skin irritation; 
inflammation; nausea; vomit.  
 long term: cancer, kidney and liver damage, 
strokes and gene mutation, possible teratogenic 
effects 
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other bird species from Britain (Shore et al., 1999) or Neatherlands (Stronkhorst et al., 
1993).  These high PAHs concentrations can be still due to the Prestige incident, in 
2010, or industrial or domestic spills in Ria de Aveiro (Vidal, Domínguez and Luís, 
2011).  In another study devoted to human exposure, between April and June of 2010, 
PM10 were measured inside and outside school buildings at suburban and center of 
Aveiro region. In Aveiro region, was found that suburban schools were exposed with 
more intensity to volatile organic compounds (VOCs) from industrial emissions than 
schools at the city center. The I/O ratios were higher in outdoor air than in indoors air 
space at schools, so it is possible that the main emission sources was vehicles smoke 
emission, biomass burning from restaurants and bakeries (Pegas et al., 2012).   
The majority of PAHs measurements in human tissues rely on HPLC and mass 
spectrometer measurements, which may be considered expensive and time consuming. 
The development and use of other methodologies to increase rapidity and cost-
efficiency can be promising as screening techniques (Li et al., 2011; Yu et al., 2011; 
Machado et al., 2014). Therefore methodologies based on PAHs properties like 
fluorescence have been developed, with the use of fluorimeters or a technique of fixed 
wavelength fluorescence. These methodologies can therefore provide a first screening 
insight on possible PAHs human exposure, helping stakeholders to act in a more 
efficient and prompt way, considering that PAHs exposure can lead to mutagenic, 
carcinogenic and teratogenic problems (Kim et al., 2013).  
 
Main objectives  
Considering the above, this study aims at determining potential human exposure to 
PAHs in the Aveiro region, Portugal, focusing on fetal exposure and relating maternal 
to fetus chemical transfer. For that, maternal and fetal matrices were collected (placenta, 
umbilical cord and mother blood) from parturient at the Infante D. Pedro Aveiro 
Hospital, Baixo Vouga Lagunar Medical Center and PAHs levels and metabolite types 
were quantified. PAHs levels were related to information gathered from questionnaires 
filled by parturient to infer on the influence of daily habits on PAHs exposure and 
accumulation, with special attention on information regarding smoke habits, industrial 
smoke and chemicals and motor combustion smoke exposure. 
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After this first chapter (Introduction), where state of the art on PAHs exposure and 
effects are described, this dissertation includes two additional chapters:  
 Chapter II: “Polycyclic aromatic hydrocarbons levels in parturient and newborns from 
Aveiro region, Portugal”. In this study, PAHs types were reported from placenta, 
umbilical cord blood and mothers’ blood from 49 mothers/newborn pairs. Four 
PAHs species (naphthalene, phenanthrene, pyrene and BaP equivalents) were 
measured by a fixed wavelength fluorescence methodology in human placenta and 
blood (plasma and blood cells). The higher PAHs concentrations were found in 
homogenized placenta and were of naphthalene equivalents.  
 Chapter III: In this chapter, there are a description of the major conclusions of the 
dissertation and perspectives of future studies.   
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Abstract 
Humans can be exposed to different PAHs since they are considered ubiquitous 
environmental contaminants that arise from several natural and anthropogenic sources. 
PAHs are considered a group of persistent priority chemicals that present carcinogenic 
and teratogenic effects on organisms. Therefore, it is crucial to monitor and study 
human exposure to PAHs, namely during fetal development, which is considered a 
sensitive window of exposure to contaminants. The main goals of this study were: (i) to 
assess maternal and fetal exposure to PAHs in parturient from the Aveiro region using 
placenta and blood as biological matrices; (ii) to examine the influence of 
environmental, sociodemographic, lifestyle and smoking habits that may contribute to 
PAHs exposure during pregnancy in Aveiro region, Portugal. For this, a fast screening 
tool based on the inherent fluorescence properties of PAHs (dependent on their number 
of benzene rings) was used to quantify the levels of 2-, 3-, 4- and 5-ring PAHs 
equivalents in human biological matrices. 
In this study, 49 mother/newborn pairs from the Aveiro region were used after their 
agreement and ethical consent. Parturient filled a questionnaire on their daily habits and 
personal details and biological samples were collected, namely, placenta, umbilical cord 
blood and mothers’ blood. Fixed fluorescence wavelength was used to quantify levels of 
PAHs in the tissues collected after calibration and determination of the techniques LOD 
and LOQ for each standard compound used using the respective exc/em wavelength 
pair. 
In general, within the matrices studied, the studied group presented higher levels of 
PAHs equivalents in placenta (total homogenate fraction) and lower levels in the 
umbilical cord blood. Low molecular weight PAHs (naphthalene and phenanthrene) 
measured in placenta presented higher levels than high molecular weight PAHs (pyrene 
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and benzo[a]pyrene). Considering the county of residence, the highest PAHs levels in 
placenta were found in parturient from Aveiro, Ílhavo and Albergaria-a-Velha and the 
lowest levels were observed in parturient from Águeda. Moreover, increased levels of 
naphthalene and phenanthrene equivalents were associated with mothers’ exposure to 
vehicle exhaust, while high levels of benzo[a]pyrene equivalents were associated with 
their exposure to tobacco smoke at work. The highest levels of naphthalene, 
phenanthrene and BaP equivalents were found in homogenized placenta of mothers who 
smoked during the third trimester of pregnancy. No significant correlations were found 
between levels of PAHs equivalents in biological matrices studied and anthropometric 
measures of newborns, but in general, high levels of PAHs equivalents were found in 
newborns that presented low body weight and length, as well as, smaller head 
circumference.  
Biomonitorization of newborns and parturient can be a major asset in evaluating 
environmental exposure to contaminants, which can also provide high value information 
for preventive medicine. A different method was adapted for detection of low- and high 
molecular PAHs equivalents in tissues seems to be a fast and sensitive screening 
biomarker tool that allows analyses of large quantities of samples. 
 
Keywords: Polycyclic aromatic hydrocarbons, pre-natal exposure, biomonitoring, 
biomarkers of exposure, human blood, human placenta. 
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 2.1 Introduction 
 
Polycyclic aromatic hydrocarbons (PAHs) are a group of persistent organic 
compounds constituted by fused or condensed aromatic benzene ring structures. The 
number of benzene ring structures can vary between 2 and 7, which is the basis for their 
classification as low molecular weight (LPAHs; 2- and 3-benzene rings) and high 
molecular weight PAHs (HPAHs; above 4-benzene rings) (Kim et al., 2013).  PAHs can 
be transported in human matrices (e.g. blood) depending on the physic-chemical 
properties such as water solubility, hydrophobicity, molecular weight and size. Low 
molecular weight PAHs have a smaller size, are found in volatile phase and have a 
smaller Kow, mainly. High molecular weight PAHs have a bigger size, found adsorbed 
in particulate phase and have larger Kow (Kim et al., 2013; Jeong et al., 2018). Thus, 
naphthalene (with two benzene rings; log Kow =3.37) and phenanthrene (three rings; 
log Kow= 4.57) are examples of LPAHs, whereas, pyrene (four rings; log Kow = 4.88) 
and benzo[a]pyrene (BaP; five rings; log Kow= 6.04) are examples of HPAHs 
(Annamalai and Namasivayam, 2015; Abdel-Shafy and Mansour, 2015).  The PAHs 
species with a larger Kow (log Kow > 2) tend to accumulate in tissues (Stronkhorst et 
al., 1993).  
In the environment, PAHs can occur in vapour phase or bound to airborne particles 
that might be associated also with other pollutants. However, PAHs phase depends on 
the atmospheric conditions, their properties and origin. Moreover, PAHs are also 
present in soil, water and food due to deposition (Kim et al., 2013). Most of the 
anthropogenic sources arise from the combustion of organic materials. However, there 
are other anthropogenic sources like the incomplete burn of garbage, tobacco and fuel. 
Forest fires and volcanic eruptions are considered natural sources of PAHs (Kim et al., 
2013; Urbancova et al., 2017) 
Therefore, humans are frequently exposed to these persistent organic pollutants 
through natural and/or anthropogenic sources. Human exposure to PAHs can occur 
through inhalation, ingestion or skin contact (Kim et al., 2013) and bioaccumulation in 
tissues and deleterious effects are expected to occur depending on their physico-
chemical properties, exposure route and origin (Sexton et al., 2011; Kim et al., 2013; 
Chen et al., 2014; Machado et al., 2014; Yin et al., 2016; Urbancova et al., 2017).   
Human health effects are related to short (eye and skin irritation; inflammation; 
nausea; vomit) (Kim et al., 2013) and long term exposures, which may  cause endocrine 
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disruption (Yin et al., 2016) mutagenic, teratogenic and carcinogenic problems (IARC, 
2010; Kim et al., 2013; Chen et al., 2014),  fetal development toxicity and repercussions 
in human reproduction (Yu et al., 2011),  risk of cell damage and cardiopulmonary 
problems (Kuo et al., 2003), and ultimately death.   
Epidemiological studies require biomarkers to quantify the individual exposure, 
population susceptibility and health effects (Suk, Collman and Damstra, 2014).  Urine 
and blood are the more common used and both considered good biological matrices for 
human biomonitoring. Blood is known to have a lower potential to accumulate PAHs 
than other tissues and/or organs (Pleil et al., 2010), since these compounds tend to 
accumulate in more lipophilic tissues or organs due to their lipophilic nature. However, 
a previous study showed that high levels of PAHs were accumulated in maternal blood 
(Sexton et al., 2011).  Placenta is also referred as a useful matrix when aiming at 
evaluates both maternal and fetal exposure to contaminants, mother to fetal 
transference, development toxicity and newborns health status. This is a large and 
discoid organ whose main functions are related to fetal growth and development, 
nutrient and excretion transference and has also metabolic and endocrine functions 
(Bauer et al., 1998; Machado et al., 2014).  The placenta has been used in 
epidemiological and biomonitoring studies since 1974 (Baglan et al., 1974), as a non-
invasive matrix that provides relevant information about xenobiotics bioaccumulation. 
In the study of Yu et al. (2011) and Sexton et al. (2011) the accumulation of  different 
PAHs (naphthalene, acenaphthylene, acenaphthene, fluorine, phenanthrene, anthracene,  
fluoranthene, pyrene, benz[a]anthracene, chrysene, benzo[b]fluoranthene, 
benzo[k]fluoranthene, benzo[a]pyrene, dibenz[a,h]anthracene, indeno[l,2,3-cd]pyrene 
and benzo[g,h,i]perylene) were reported in human placenta.  Moreover, Machado et al. 
(2014) found that PAHs can be transmitted from mother to fetus blood through 
placenta. Other studies found significant correlations between levels of low molecular 
weight (LPAHs) in the placenta, human milk and umbilical cord blood also suggesting 
their transfer from the mother to the fetus (Yu et al., 2011).   
Although it is commonly known that PAHs exposure can be harmful in adulthood, 
pre-natal and childhood exposure can lead to a higher risk since it represents a sensitive 
window of human development where a smaller body mass has to cope already in an 
early stage with contaminant load (Tang et al., 2014).   
In this context, the present study has the following main goals: (i) to assess maternal 
and fetal exposure to PAHs in parturient from the Aveiro region using placenta and 
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blood as biological matrices, and (ii) to examine the influence of environmental, 
sociodemographic, lifestyle and smoking habits that may contribute to PAHs exposure 
during pregnancy in Aveiro region, Portugal. Moreover, it was intended to adapt an 
already described fast screening method described by Gravato and Santos (2003) and 
Oliva et al. (2010) to quantify PAHs equivalent levels in human matrices. The 
methodology was adjusted to microplates and can represent a useful and cheap tool 
based on PAHs fluorescence properties as function of ring numbers.  
 
2. 2. Materials and Methods 
 
2.2.1 Study Design, subjects and Sampling 
 
This work consisted in a cross-sectional study performed in the same individuals 
reported by Alves et al. (2017).  Briefly, 49 parturient women resident in Aveiro region 
were randomly selected for the study from October 2014 to April 2015 at Infante D. 
Pedro Hospital (Centro Hospitalar do Baixo Vouga, Aveiro, Portugal), during their 
delivery. Aveiro is a district located in the central-north Atlantic coast in mainland of 
Portugal, and women involved in the study had their residence in the following 
counties: Águeda; Albergaria-A-Velha; Aveiro; Estarreja; Ílhavo; Oliveira do Bairro; 
Ovar; Vagos; Sever do Vouga; Anadia.  
All parturient were interviewed before or within the first 24 hours after delivery 
using a standardized questionnaire to collect sociodemographic data, e.g. maternal age 
(years); body mass index (BMI) before pregnancy and weight gain during pregnancy 
(kg); time of residence (years); place of residence (urban or rural; next to roads with 
high traffic); maternal education (university graduated; high school graduated; primary 
graduated or attend some years in primary school); parity (0,+1); occupational exposure 
(work status -unemployed or employed-), exposure to chemicals (yes or no); smoking 
habits (yes or no or passive smoker and how many cigarettes /day), anthropometric data 
of the newborn (head circumference; birth length; birth weight). All parturient 
participating in this study were informed and signed the consent form. Furthermore, this 
study was approved by the Ethics Committee of Infante D. Pedro Hospital in Centro 
Hospitalar do Baixo Vouga, Aveiro.  
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Regarding the methods and procedures, placenta and blood samples from 
parturient and umbilical cord were collected and stored at -80ºC until further analysis.  
The placenta tissue was defrosted on ice and homogenized with phosphate buffer 0.1M 
pH 7.4 (100 mg tissue per 1 mL buffer) using an ultrasonic cell disruption procedure 
(Branson 250 sonifier). Part of the homogenized placenta was centrifuged (10.000 g; 20 
min; 4ºC) to obtain the supernatant (soluble part of the cells, the cytosol). Both 
homogenized placenta and supernatant fractions were stored in -80ºC freezer until 
further analysis. Blood samples from parturient and umbilical cord were collected and 
stored in anticoagulant and the plasma was separated from blood cells in the same day 
of collection through centrifugation (500 g, 5 min, 4ºC). The pure plasma was stored in 
-80ºC freezer. The blood cells pellets were ressuspended in phosphate buffer 0.1M pH 
7.4 and then stored at -80ºC.  
 
2.2.2 Quantification of protein content 
 
The method of Bradford (1976) adapted to microplate was used for protein 
quantification in all the samples of placenta, plasma and blood cells using a wavelength 
of 600 nm (Lab system Multiskan EX microplate reader) and gamma-globulin as 
standard. Protein content was quantified in order to be used in the normalization of 
levels of PAHs present in these tissues.  
 
2.2.3 Analytical procedure for PAHs 
 
A fluorescence spectrophotometer (HITACHI F-7000) was used to quantify 
PAHs levels in the sampled tissues. Four types of PAHs were determined according to 
their number of rings using naphthalene (2-rings), phenanthrene (3-rings), pyrene (4-
rings) and benzo[a]pyrene (5-rings) as standards. Fluorescence analysis was performed 
in accordance with the method described by Oliva et al. (2010),  where naphthalene-
type PAHs or equivalents were measured at 290/335 nm (excitation/emission pair) 
(Figure 2-1), phenanthrene-type PAHs or equivalents at 259/380 nm (Figure 2-2), 
pyrene-type PAHs or equivalents at 341/383 nm (Figure 2-3) and benzo[a]pyrene-type 
PAHs or equivalents at 380/430 nm (Figure 2-4). Each standard curve was performed 4 
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times and each standard was measured in 4 replicates at each time a curve was 
performed. 
Then, equivalents of these 4 PAHs were quantified in mothers’ blood cells and 
blood plasma, umbilical’ cord cells and plasma, as well as, homogenized samples and 
S9 fraction or supernatant of placenta. Concisely, plasma, blood cells and placenta 
samples were defrosted at room temperature (25ºC) and were further diluted in 
methanol 50% in a 1:30 proportion. Then, microtubes were sonicated (P Electra 
ultrasonic) for 1 minute and 4 technical replicates per sample were used in a 96-well 
microplate to quantify levels of PAHs equivalents according to their number of benzene 
rings.  
 
 
 
Figure 2-1 - Fluorescence intensity using a range of concentrations of 3.91 until 125 µg/mL 
naphthalene. Each concentration of naphthalene was determined 4 times and for each 
determination 4 replicates were done, including a control, with no contaminant added. Linear 
adjustment (R2) and equation are shown in the figure. Linear equation was used for the calculation 
of naphthalene equivalents in samples. 
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Figure 2-2 - Fluorescence intensity using a range of concentrations of 3.91 until 62.5 µg/mL 
phenanthrene. Each concentration of phenanthrene was determined 4 times and for each 
determination 4 replicates were done, including a control, with no contaminant added. Linear 
adjustment (R2) and equation are shown in the figure. Linear equation was used for the calculation 
of naphthalene equivalents in samples. 
 
 
 
 
Figure 2-3 - Fluorescence intensity using a range of concentrations of 3.91 until 125 µg/mL pyrene. 
Each concentration of pyrene was determined 4 times and for each determination 4 replicates were 
done, including a control, with no contaminant added. Linear adjustment (R2) and equation are 
shown in the figure. Linear equation was used for the calculation of naphthalene equivalents in 
samples. 
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Figure 2-4 - Fluorescence intensity using a range of concentrations of 3.91 until 125 µg/mL 
benzo[a]pyrene (BaP). Each concentration of BaP was determined 4 times and for each 
determination 4 replicates were done, including a control, with no contaminant added. Linear 
adjustment (R2) and equation are shown in the figure. Linear equation was used for the calculation 
of naphthalene equivalents in samples. 
 
 
 
 
2.2.4 Limit of Detection (LOD) and Limits of Quantification (LOQ) 
 
Limits of detection (LOD) and limits of quantification (LOQ) were calculated 
for the present methodology for the different PAHs equivalents measured as described 
by (Shrivastava and Gupta, 2011). For naphthalene equivalents the LOD obtained was 
23.55 µg/mL and the LOQ set was 78.51 µg/mL. For phenanthrene equivalents LOD 
and LOQ calculated were 0.602 µg/mL and 2.01 µg/mL, respectively. For pyrene 
equivalents LOD and LOQ calculated were 0.174 µg/mL and 0.579 µg/mL. Lastly, for 
Benzo[a]pyrene equivalents a LOD of 0.004 µg/mL and a LOQ of 0.014 µg/mL were 
obtained. 
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2.2.5 Cotinine levels in parturient 
 
 Cotinine, a metabolite of nicotine, was measured in the plasma of parturient in 
order to assess tobacco smoke exposure. The quantification was performed using a 
commercial ELISA Kit (Sigma Aldrich) following the instructions of the manufacturer.  
 
2.2.6 Statistics analysis  
 
Non-parametric tests were performed since data did not present normality and/or 
homoscedasticy (Shapiro-Wilk tests). Spearman correlation analysis was carried out 
between PAHs equivalents levels in the different matrices analyzed, namely in the 
placenta (homogenized and supernatant), blood cells (from mother and umbilical cord) 
and plasma (mother and umbilical cord). A Spearman correlation analysis was also 
performed between cotinine level in the parturient plasma and levels of PAHs 
equivalents in all biological matrices. To test for significant differences between groups 
(related to smoking habits, area of residence, newborns weight, cephalic perimeter and 
length) a student t-test (for 2 groups) or a One-Way ANOVA (3 groups) analysis was 
performed. Post-hoc tests were performed when necessary, i.e. Dunn’s test. Statistical 
analyses were performed using the software SigmaPlot for Windows, version 12.0. 
Potential influence variables (e.g. lifestyle, smoking habits, area of residence and 
others) on the retrieved PAHs levels in placenta and blood matrices were analyzed using 
redundancy analysis (RDA). Forward selection was used in RDA for the selection of the 
subset of variables giving the best explanatory model. A Monte Carlo permutation test 
using 499 permutations was used to calculate the significance of each explanatory 
variables. The environmental factors with p<0.05 were included in the constrained 
ordination model. The analysis was carried out by CANOCO 4.5 software.  
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2.3. Results 
2.3.1 Demographic Characteristics  
Socio-demographic and clinical characteristics from 49 mother/newborn pairs 
enrolled in this study were resident in 11 municipalities from Aveiro region: 18 from 
Aveiro city, 9 from Ílhavo, 5 from Oliveira do Bairro, 4 from Estarreja, 4 from Murtosa, 
3 from Águeda, 3 from Abergaria-a-Velha, 2 from Vagos and 1 from Ovar (Table 2-1). 
From all participants, according the questionnaire, 41% of the participants lived in 
urban areas and 35% in rural areas (Table 2-S1). The remaining participants lived in 
areas classified as intermediate, between urban and rural areas according the 
questionnaire answers (Table 2-S1). Other socio-demographic data can be found in 
Table 2-1.  
 
 
Table  2-1 - Socio-demographic and clinical characteristics of mother newborn pairs.  
 
 
 
 
 
Clinical and Demographic 
Characteristics MEAN ± SD OR % N 
Age (Years) 30.1±5.8 49 
BMI before pregnancy (kg/m2) 29.6±4.2 49 
Municipality of residence (%)   
Aveiro 36.7 18 
Ílhavo 18.4 9 
Oliveira do Bairro 10.2 5 
Estarreja 8.2 4 
Murtosa 8.2 4 
Águeda 6.1 3 
Albergaria-a-Velha  6.1 3 
Vagos  4.1 2 
Ovar 2.0 1 
Time of residence (years) 17.3±12.4 49 
Education Level (%)   
Primary incomplete 4.1 2 
Primary complete 10.2 5 
High School  49.0 24 
University 36.7 18 
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2.3.2 PAHs in placenta and blood 
Values of PAHs equivalents levels below LOD were not included in data analysis. In 
general, the four PAHs levels were significantly higher in the fraction of homogenized 
placenta than in the umbilical cord blood and mothers’ blood fractions (plasma or blood 
cells) analyzed (Dunn’s post-hoc test; p<0.05; Tables 2-2, 2-3, 2-4 and 2-5.). 
Considering both fractions assessed in placenta, no significant differences on PAHs 
levels were obtained between the supernatant fraction and the homogenate fraction 
(p>0.05). Furthermore, each PAH-type equivalents determined in the umbilical cord 
blood fractions (plasma or blood cells)  presented similar levels when compared to 
mother blood fractions (Dunn’s post-hoc test; p>0.05). 
 
 
 
Table  2-2 - Naphthalene equivalents levels above LOD determined in biological matrices: placenta, 
umbilical cord blood and parturient blood. Values reported correspond to the average, standard 
deviation (SD), median, percentiles (P25 and P75), minimum (Min), maximum (Max) and N are 
presented. Values are expressed in µg/mg protein. 
 
Naphthalene N Average SD Median P25 P75 Max Min 
Homogenized 
placenta 49 8.03
a 3.24 7.25 6.09 9.62 18.49 2.21 
Umbilical 
cord blood 
cells  
14 0.10b 0.03 0.09 0.08 0.11 0.15 0.05 
Parturient 
blood cells  4 0.09
b 0.01 0.09 0.11 0.08 0.08 0.10 
a,b. Different letters represent  significant differences (Dunn’s post-hoc; p<0.05). 
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Table 2-3 - Phenanthrene equivalents levels above LOD determined in biological matrices: 
placenta, umbilical cord blood and parturient blood. Values reported correspond to the average, 
standard deviation (SD), median, percentiles (P25 and P75), minimum (Min), maximum (Max) and 
N are presented. Values are expressed in ng/mg protein. 
 
Phenanthrene N Average SD Median P25 P75 Max Min 
Homogenized 
placenta 49 285
a 125 264 201 353 690 48 
Supernatant  
Placenta 6 44
a,b 19.44 37.85 32.6 45.95 82.1 30.5 
Umbilical 
cord blood 
cells 
9 2.98c 0.735 2.65 2.34 3.57 4.13 2.23 
Umbilical 
cord plasma 32 8.93
c,d 3.84 7.72 6.61 9.7 2.43 5.34 
Parturient 
plasma 36 12.77
b,d 4.73 11.35 9.80 14.83 29.8 7.51 
a,b,c,d Different letters represent significant differences (Dunn’s post-hoc test; p<0.05). 
 
 
 
Table 2-4 - Pyrene equivalents levels above LOD determined in biological matrices: placenta, 
umbilical cord blood and parturient blood. Values reported correspond to the average, standard 
deviation (SD), median, percentiles (P25 and P75), minimum (Min), maximum (Max) and N are 
presented. Values are expressed in ng/mg protein. 
 
Pyrene N Average SD Median P25 P75 Max Min 
Homogenized 
placenta 10 23.22
a 16.81 16.8 12.98 26.88 65.9 10.8 
Supernatant 
placenta 8 15.41
a 6.14 13.9 10.9 17.33 28.2 9.55 
Umbilical 
cord plasma 9 3.66
b 2.83 2.64 2.24 3.30 10.2 0.85 
Parturient 
plasma 13 4.06
b 2.92 2.92 2.36 3.86 12.5 2.02 
a,b Different letters represent significant differences (Dunn’s post-hoc test; p<0.05). 
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Table 2-5 - Benzo[a]pyrene (BaP) equivalents levels above LOD determined in biological matrices: 
placenta, umbilical cord blood and parturient blood. Values reported correspond to the average, 
standard deviation (SD), median, percentiles (P25 and P75), minimum (Min), maximum (Max) and 
N are presented. Values are expressed in ng/mg protein. 
 
BaP N Average SD Median P25 P75 Max Min 
Homogenized 
placenta 13 3.18
a 2.82 2.06 1.25 3.29 8.39 0.53 
Supernatant 
placenta 5 2.73
a 2.34 2.67 2.83 2.83 6.53 0.73 
Umbilical 
cord plasma 13 0.39
b 0.24 0.29 0.21 0.58 0.81 0.08 
Parturient 
plasma 14 0.40
b 0.36 0.29 0.15 0.54 1.28 0.06 
 
a,b Different letters represent significant differences (Dunn’s post-hoc test; p<0.05). 
 
 
 
Naphthalene equivalents measured in the homogenized placenta were not 
significantly correlated with those measured in the umbilical cord cells (r=0.216; 
p=0.136) (data not shown). No other correlations were performed for naphthalene 
equivalents in other matrices since they were below LOD (data not shown). Considering 
levels of phenanthrene equivalents measured in the different matrices studied, the only 
significant correlation found was between their levels in umbilical cord plasma and 
mother plasma (Table 2-6.).  
 Levels of pyrene equivalents and benzo[a]pyrene equivalents quantified in the 
different placenta (homogenate and supernatant) and plasma (mother and umbilical 
cord) fractions were all significantly correlated with each other (p<0.05; Table 2-7 and 
2-8), with the exception between levels of benzo[a]pyrene equivalents in homogenized 
placenta and their respective supernatant (p>0.05).   
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Table 2-6 - Spearman correlation analysis between the levels of phenanthrene equivalents in 
placenta (homogenate and supernatant fractions), umbilical cord blood (cells and plasma) and 
mothers’ plasma. Values refer to Spearman correlation coefficient (r) and respective p values 
(between brackets). 
 
Phenanthrene Homogenized 
placenta 
Supernatant 
placenta 
Umbilical 
cord blood 
cells 
Umbilical 
cord 
plasma 
Parturient 
plasma 
Homogenized 
placenta 
 0.0269 
     (0.854) 
0.259 
(0.0754) 
0.0771 
(0.597) 
0.177 
(0.223) 
Supernatant 
placenta 
  -0.0307 
(0.835) 
0.241 
(0.0951) 
0.211 
( 0.146) 
Umbilical 
cord blood 
cells 
   0.00528 
(0.971) 
-0.0816 
(0.580) 
Umbilical 
cord plasma 
    0.578 
(<0.001) 
Parturient 
plasma 
     
 
 
 
 
 
 
Table 2-7 - Spearman correlation analysis between the levels of pyrene equivalents in placenta 
(total homogenate and supernatant fractions), umbilical cord blood plasma and mothers’ plasma. 
Values refer to Spearman correlation coefficient (r) and respective p values (between brackets). 
 
Pyrene 
 
Homogenized 
placenta 
Supernatant 
placenta 
Umbilical cord 
plasma 
Parturient 
plasma 
Homogenized 
placenta  
0.630 
(<0.001) 
0.582 
(<0.001) 
0.374 
(<0.001) 
Supernatant 
placenta   
0.713 
(<0.001) 
0.507 
(<0.001) 
Umbilical cord 
plasma 
 
   0.604 (<0.001) 
Parturient 
plasma     
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Table 2-8 - Spearman correlation analysis between the levels of benzo[a]pyrene (BaP) equivalents 
in placenta (homogenate and supernatant fractions), umbilical cord blood plasma and mothers’ 
plasma. Values refer to Spearman correlation coefficient (r) and respective p values (between 
brackets). 
 
BaP 
 
Homogenized 
placenta 
Supernatant 
placenta 
Umbilical cord 
plasma 
Parturient 
plasma 
Homogenized 
placenta  
0.243 
(0.0924) 
0.673 
(<0.001) 
0.472 
(<0.001) 
Supernatant  
Placenta   
0.509 
(<0.001) 
0.503 
(<0.001) 
Umbilical cord 
plasma    
0.756 
(<0.001) 
Parturient 
plasma 
    
 
 
2.3.3 Anthropometric data of newborns and PAHs levels in placenta and 
blood 
Body weight and head circumference at birth was significantly smaller in female 
newborns than in male newborns (t-student test; p<0.05) (Table 2-9.). Newborn males at 
birth had an average length of 50 cm (±1.4), weight 3319.4 g (± 381.4) and head 
circumference of 34.9 (±0.92), whereas females had a birth length of 49 cm (±1.6) and 
weight of 3135.1 g (±369.2) and head circumference of 33.9 (± 0.83) . There were no 
significant correlations between the levels of naphthalene, phenanthrene, pyrene and 
BaP equivalents measured in placenta and anthropometric data of newborns (data not 
shown). Despite that, is noteworthy that almost all correlation coefficients obtained 
were negative. 
Pyrene equivalent content in homogenized placenta was significantly higher 
(p=0.042) in the group of newborns that presented a weight at birth below 3 kg. 
Moreover, levels of BaP equivalent in placenta were higher (p=0.05) in newborns with a 
length below 35 cm at birth. Although no significant correlations were established, it 
was possible to observe patterns for higher levels of naphthalene and phenanthrene 
equivalents when newborns had lower weight, length and cephalic perimeter at birth 
(Table 2-10). 
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Table  2-9 - Anthropometric data of the newborns. 
 
Birth outcomes  AVERAGE ± SD or % N 
Gender (%)   
Male 51.0 25 
Female 49.0 24 
Birth length (cm)   
Male 49.9±1.4 25 
Female 49.0±1.6 24 
Birth weight (g)   
Male 3319.4±381.4 25 
Female 3135.1±369.2 24 
Head circumference (cm)   
Male 34.9±0.92 25 
Female  33.9±0.83 24 
 
 
Table 2-10 - Naphthalene, phenanthrene, pyrene and benzo[a]pyrene equivalents levels in placenta 
(homogenate fraction) grouped by newborns weight, cephalic perimeter and length. SD-Standard 
deviation. Values represent average ± standard deviation and are expressed in µg/mg protein. 
 
Naphthalene Phenanthrene Pyrene Benzo[a]Pyrene 
Newborn weight (Kg) 
>3kg 7.74±3.03 0.27±0.13 0.01±0.003 3.27x10
-03 
±0.003 
≤3kg 8.27±3.72 0.30±0.13 0.04±0.02 * 
3.05x10-03 
±0.002 
Cephalic perimeter (cm) 
≥35 7.47±3.51 0.26±0.14 0.01±0.01 0.004±0.004 
<35 8.09±3.28 0.28±0.12 0.02±0.02 0.003±0.003 
Newborn Length (cm) 
≥50 7.38±2.09 0.25±0.10 0.01±0.01 0.002±0.003 
<50 8.35±4.21 0.29±0.15 0.02±0.02 0.004±0.003* 
* represent significant differences between the groups (t-student test; p<0.05). 
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2.3.4 Smoking habits and PAHs in placenta and blood  
The levels of naphthalene, phenanthrene and benzo[a]pyrene equivalents in 
placenta (homogenate fraction) were higher in parturient that reported who exhibit 
smoking habits during and/or before pregnancy (Table 2-11), although no significant 
differences were registered (t-student test; p>0.05). Only six of the forty nine parturient 
smoked during the last trimester of pregnancy (1-10 cigarettes per day). Significant 
correlations were obtained between phenanthrene equivalents determined in parturient’s 
plasma and cotinine levels (Table 2-S2; r=-0.464; p=0.005) and the correlation of 
cotinine levels with levels of phenanthrene equivalents in the supernatant fraction of 
placenta was attained (p=0.05; r=0.829).   No significant correlations were obtained 
between the naphthalene, pyrene and BaP equivalents levels in the biological matrices 
and cotinine levels measured in plasma of parturient. 
 
Table  2-11 - Naphthalene, phenanthrene, pyrene and benzo[a]pyrene equivalents levels in placenta 
of smoker and non-smoker parturient (before and/or during pregnancy). Values are presented as 
average ± standard deviation and are expressed in µg/mg protein. 
 
However,  levels of naphthalene equivalents in homogenized placenta revealed 
significant differences between the different groups of parturient classified according to 
their type of passive smoking in the work place (never, sporadically, daily (1hour); daily 
(more than 3 hours); one-way ANOVA; p<0.05). Similarly, levels of phenanthrene 
equivalents were also significantly different in groups referring different passive 
smoking habits at home (one-way ANOVA; p>0.05; Table 2-S3). However, in both 
cases, Dunn’s post-hoc testing did not revealed statistical differences between the 
groups. Furthermore, according to the RDA analysis performed (Figure 2-5), the levels 
of benzo[a]pyrene equivalents in placenta and plasma (mother and umbilical cord) were 
positively correlated with the exposure to smoke at work (F=3.055; p=0.0460; Figure 2-
5).  
Homogenized  
Placenta  Naphthalene Phenanthrene Pyrene BaP N (%) N 
Smoke  
Yes  8.23±4.35 0.86±2.39 0.01±0.002 3.96x10
-03 
±0.004 
34.5
% 17 
No 7.92±2.55 0.28±0.10 0.03±0.02  
3.04x10-03 
±0.003 
65.3
% 32 
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Figure 2-5 - Biplots based on redundancy analysis (RDA) representing the correlation between 
naphthalene, phenanthrene, pyrene and BaP equivalents levels in biological matrices (blood and 
placenta) and significant influence variables (parturient passive smoking at work and residence 
near roads, highlighting cars and/or heavy vehicles traffic like trucks). 
 
 
The maximum levels of naphthalene (18.49 µg/mg protein) and phenanthrene 
equivalents (0.69 µg/mg protein) registered were found in placenta of parturient who 
smoked in the last trimester of pregnancy. The levels of naphthalene, phenanthrene and 
BaP equivalents were in fact higher in homogenized placenta of women that smoked in 
last trimester of pregnancy, but no significant differences were registered (p>0.05) 
(Figure 2- 6.). 
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Figure 2-6 - Naphthalene, phenanthrene and benzo[a]pyrene equivalents levels in placenta of non-
smoker (1) and smoker (2) parturient during the 3rd trimester of pregnancy. Values represent mean 
± standard deviation and are expressed in µg/mg protein. 
 
2.3.5 Area of parturient residence 
Low molecular weight PAHs (naphthalene and phenanthrene equivalents) and pyrene 
equivalents measured in homogenized placenta presented relatively higher levels (non-
significant differences; p>0.05; Table 2-S1) in parturient living in rural locations. 
Parturient living nearby traffic roads, where cars and/or heavy road vehicles were 
constantly passing, also presented relatively high levels of PAHs equivalents (Table 2-
S1). Namely, LPAHs in homogenized placenta presented significant differences 
between the different groups of parturient taking into account the presence of heavy 
road vehicles nearby their residence (one-way ANOVA for naphthalene equivalents, 
p=0.03; one-way ANOVA for phenanthrene equivalents; p=0.041) (Table 2-S1), 
although Dunn’s post-hoc testing did not revealed statistical differences between those 
groups. According to the RDA analysis (Figure 2-5) the levels of phenanthrene 
equivalents in homogenized placenta and plasma (mother and umbilical cord) and of 
naphthalene equivalents in homogenized placenta were positively related with vehicle 
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exhausts, namely with areas of parturient residence next to roads where cars and/or 
heavy vehicles pass constantly (trucks; RDA analysis, F=2.446; p=0.0280 and cars; 
RDA analysis, F=2.302; p=0.0320). Further details concerning parturient work place 
and chemicals exposure at work are presented in Table 2-S4. 
 
2.3.6 PAHs levels in placenta along Aveiro district 
In Tables 2-12, 2-13, 2-14 and 2-15 levels of the 4 PAHs types in placenta are 
displayed according to the county of parturient’s residence in Aveiro district. No 
significant differences were registered between the levels of PAHs from parturient of 
the different counties (p>0.05). However, it is noteworthy that naphthalene and 
phenanthrene equivalents presented the highest levels in parturient from Aveiro and 
Ílhavo counties (Tables 2-12 and 2-13). Due to the fact that pyrene and benzo[a]pyrene 
equivalents in homogenized placenta were below the detection limits in samples from 
some counties, the respective means are not presented, or presented with a reduced 
number of samples (Tables 2-14 and 2-15).  
 
Table 2-12 - Levels of naphthalene equivalents in homogenized placenta of 49 mother/newborn 
pairs from different municipalities of the Aveiro district, Portugal. Values represent mean ± 
standard deviation and are expressed in µg/mg protein. 
 
County of residence Number of parturient (N) Naphthalene equivalents (Mean ± SD) 
Aveiro 18 8.61±3.61 
Ílhavo 9 8.60±4.13 
Oliveira do Bairro 5 7.65±2.43 
Estarreja 4 8.26±1.95 
Murtosa 4 6.77±1.46 
Águeda 3 5.27±2.67 
Albergaria-a-Velha 3 8.30±5.00 
Vagos 2 7.65 
Ovar  1 6.80 
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Table  2-13 - Levels of phenanthrene equivalents in homogenized placenta of 49 mother/newborn 
pairs from different municipalities of the Aveiro district, Portugal. Values represent mean ± 
standard deviation and are expressed in µg/mg protein. 
 
Demographic 
Characteristics 
(Residence) 
Number of parturient (N) Phenanthrene equivalents (Mean ± SD) 
Aveiro 18 0.30±0.15 
Ílhavo 9 0.31±0.16 
Oliveira do Bairro 5 0.27±0.09 
Estarreja 4 0.28±0.07 
Murtosa 4 0.24±0.07 
Águeda 3 0.20±0.07 
Albergaria-a-Velha 3 0.30±0.20 
Vagos 2 0.28 
Ovar  1 0.23 
 
 
Table  2-14 - Levels of pyrene equivalents in homogenized placenta of 49 mother/newborn pairs 
resident in different municipalities of the Aveiro district, Portugal. Values represent mean ± 
standard deviation and are expressed in µg/mg protein. 
 
Demographic 
Characteristics 
(Residence) 
Number of parturient (N) Pyrene equivalents levels (Mean ± SD) 
Aveiro 5 0.02±0.009 
Ílhavo 1 0.03 
Oliveira do Bairro 1 0.01 
Águeda 2 0.04 
Ovar 1 0.01 
 
 
Table  2-15 - Levels of benzo[a]pyrene (BaP) equivalents in homogenized placenta of 49 
mother/newborn pairs inform different municipalities  of the Aveiro district, Portugal. Values 
represent mean ± standard deviation and are expressed in µg/mg protein. 
 
Demographic 
Characteristics 
(Residence) 
Number of parturient (N) BaP equivalents (Mean ± SD) 
Aveiro 2 0.005 
Ílhavo 5 0.002±0.001 
Estarreja 2 0.005 
Murtosa 2 0.002 
Águeda 1 0.007 
Vagos  1 0.0005 
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2.4. Discussion  
 
2.4.1 PAHs in Placenta and blood 
In the present study, levels of PAHs equivalents in placenta were in general 
higher than in blood cells (mother and umbilical cord) or plasma (mother and umbilical 
cord). In fact, placenta can act as a barrier to xenobiotics, including PAHs, partially 
preventing them to reach the fetus. Due to their lipophilic nature, PAHs can penetrate 
though the cells membranes, including those of placenta leading to PAHs accumulation 
(Myllynen, Pasanen and Pelkonen, 2005; Kumar et al., 2014).  In this study, 
phenanthrene, pyrene and BaP equivalents presented similar content in mothers’ plasma 
and in the umbilical cord plasma, suggesting that placenta indeed act as a partial but not 
complete barrier for this type of PAHs. Several studies have reported PAHs levels in 
these maternal-fetus matrices, depending on the exposure scenarios.  Some studies show 
evidence of patterns similar to the ones of the present study, with BaP equivalents 
showing lower concentrations in umbilical cord blood when compared to the placenta 
measurements (e.g. Madhavan and Naidu, 1995; Yu et al., 2011).  Another finding that 
can relate to the barrier role of placenta is the detection of BaP equivalents at higher 
levels in mothers’ plasma than umbilical cord plasma (Radmacher, Looney and Myers, 
2010),  showing that partly is retained in placenta. 
Phenanthrene, pyrene and BaP equivalents levels in blood cells were bellow 
LOD. It has been suggested that plasma lipidic properties make PAHs to bind 
preferably to the plasma monolayer (Massey and Pownall, 1998).  A similar pattern has 
been described in a study where the major part of POPs were found in plasma (more 
than 50%) when compared with blood cells (Kärrman et al., 2006).  
Patterns for PAHs accumulation may also depend on the molecular structure, i.e. 
the number of rings present. In the present study, LPAHs levels were in general higher 
than HPAHs contents in tissues, which is in accordance with the study of Zhang et al., 
(2017),  where LPAHs levels were higher in placenta, umbilical cord blood and 
mothers’ blood when compared to HPAHs. 
This pattern may be related to the emission and exposure type of different PAHs, 
where LPAHs are generally found in gaseous phases of exposure, while HPAHs have a 
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bigger size and are found adsorbed to the particulate phase of exposure (e.g. through fly 
ash and soot). Therefore, their entrance in the body and consequently their 
bioaccumulation will differ (Abdel-Shafy and Mansour, 2015). Moreover, some LPAHs 
species have a similar structure to steroid hormones like E2 (Yin et al., 2016),  which 
can enable and facilitate their entrance in organs like the placenta (Yin et al., 2016).   
Even though presenting higher level, no correlation was attained between levels 
of LPAHs in the placenta and blood. So, LPAHs levels in the matrices represent a 
different organ and tissue. On the other hand, HPAHs levels in placenta were correlated 
with blood from both mother and the umbilical cord. Therefore, if this pattern is 
confirmed for other similar studies, PAHs measurements in mothers’ blood may be 
replaced by placenta with the advantage of being considered a non-invasive matrix.  
Several other studies have used the placenta as a matrix for PAHs measurements 
(e.g. Gladen et al., 2000; Yuan et al., 2013),  although the use of different 
methodologies and analytical techniques make comparisons difficult. In addition, the 
use of different biological matrices (e.g. different tissues, organs or excretions) 
dependent on the aims of the studies make somehow difficult comparing exposure 
scenarios for different population (Sexton et al., 2011).  Furthermore, there are no 
recommended threshold levels for PAHs in the human matrices analyzed in the present 
study. However, there is an indicative level for PAHs in urine to characterize parturient 
exposure to PAHs and to complement data obtained in placenta and blood matrices. A 
metabolite of pyrene quantified in urine (1OH-pyrene) is one of the most used 
biomarkers for PAHs exposure.  American Conference of Governmental Industrial 
Hygienists (ACGIH, 2010) uses this non-invasive matrix to assess total burden of PAHs 
levels in occupational groups with an indicative of 0.5 µmol 1OH-Pyrene /mol 
creatinine in urine.  
 
2.4.2 Exposure to tobacco smoke 
Lifestyle during pregnancy can reflect on fetus exposure to xenobiotics. If the 
mother is a smoker, the fetus can be exposed to different contaminants, including PAHs 
(Sexton et al., 2011).  In this study, naphthalene, phenanthrene and BaP equivalents 
levels in homogenized placenta from pregnant women who smoked during the 3rd 
trimester were higher than from those who did not smoke during this period. The same 
occurred for parturient who have smoked throughout their live time. These mothers’ 
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presented higher naphthalene, phenanthrene and BaP equivalents contents comparing to 
the non-smoking women. Furthermore, according to the redundancy analysis there was 
a significant association between BaP equivalents levels in placenta and plasma (both 
from mother and umbilical cord) and passive smoke at work. Similar findings were 
observed in the study from Machado et al. (2014), with parturient from Porto Alegre, 
Brazil, where higher BaP levels in umbilical cord blood were related to smoking habits.  
Cotinine, a metabolite of nicotine, is a commonly used marker for smoking 
habits (Barr, Bishop and Needham, 2007).  Contrarily to what was expected, in the 
present study no significant correlations were found between cotinine measured in 
parturient plasma and PAHs levels in placenta and blood matrices. Similarly Yuan et al. 
(2013) reported no association between PAH-DNA adducts in placenta and nicotine and 
cotinine in blood.  
 
2.4.3 Influence of traffic exhausts 
It is known that, PAHs like naphthalene- and phenanthrene-type PAHs can occur 
through anthropogenic emissions like coal tar, gasoline or diesel fuel combustion (Lai et 
al., 2011),  generally presented in the gaseous phase of emissions and exposures (Kim et 
al., 2013).  In the present study, higher content of LPAHs and pyrene equivalents were 
found in placenta from parturient resident in rural areas. However, naphthalene and 
phenanthrene equivalents levels were higher in parturient inhabiting next to roads with 
high traffic (cars), also confirmed by the redundancy analysis. Although rural exposure 
was not expected, we cannot disregard that women may work in city centers and be 
exposed during the day to this type of emissions. According to  Zhang, Zhang and 
Wang (2009) that discriminated the sources of 16 PAHs, it is possible to relate LPAHs 
like naphthalene and phenanthrene equivalents with coal tar combustion, specifically. 
According to Albuquerque, Coutinho and Borrego (2016) motor vehicles may cause an 
increase of PAHs in the environment.  
 
2.4.4 Influences of PAHs in anthropometric data of newborns 
High PAHs levels in the body can be one of the consequences for length, weight 
and head circumference diminution, preterm and intrauterine growth restrictions and 
other major problems like neural tube defects or abortion (Ren et al., 2011; Chen et al., 
2014).  In the studied population at Aveiro, parturient with newborns with less weight 
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had significant higher pyrene equivalents levels in homogenized placenta, while lower 
length newborns had significant higher BaP equivalents levels in homogenized placenta. 
Higher (but non-significant) levels of naphthalene, phenanthrene, pyrene and BaP 
equivalents in placenta were also found in newborns with smaller head circumference. 
According to Choi et al. (2006), PAHs higher concentration found in umbilical cord 
blood was associated with significantly reduced weight in the Krakow Caucasians and 
New Yorkers African Americans too. Additionally, Jedrychowski et al. (2013) revealed 
that prenatal airborne and dietary PAHs concentration exposure may be a possibly cause 
to the lower birth weight of the newborns in Poland. In Beijing (China) a study with 130 
patients (80 patients with neural tube defects and 50 control patients) that revealed that 
the higher PAHs means concentrations were found in patients placenta tissue with a 
serious birth defect than the PAHs concentration mean in placenta tissue of patients 
without the problem (Ren et al., 2011).  Al-Saleh et al. (2013) present that 
benzo[b]fluoranthene, benzo[a]pyrene, chrysene, benzo[a]anthracene and 
dibenzo[a,h]anthracene equivalents levels in blood (mothers’ and umbilical cord) and 
placenta may affect the anthropometric data (weight, length and head circumference). It 
is difficult to compare measured PAHs levels in umbilical cord blood, mothers’ blood 
and placenta because of the different analytical techniques and unities used in different 
studies (Sexton et al., 2011). 
 
2.4.5 PAHs levels along Aveiro region  
Considering naphthalene and phenanthrene levels in placenta of parturient 
resident in different counties of the Aveiro region, no significant differences were found 
between LPAHs levels. The high variability of data and low numbers of parturient from 
some of the counties contribute to these non-significant results. Noteworthy, a trend was 
found in LPAHs levels. Naphthalene and phenanthrene equivalents were higher in 
Aveiro, Ílhavo and Albergaria-a- Velha and lower in Águeda counties. This could occur 
because Aveiro and Ílhavo are counties with larger urban areas. However, the counties 
of Abergaria-a-Velha and Águeda have larger rural areas and they are both very 
industrialized. Despite there are several studies that reveal that PAHs concentrations are 
higher in urban areas atmosphere than in rural places (e.g. Ravindra, Sokhi and Van 
Grieken, 2008; Zhang and Tao, 2009; Wang, Zhu and Chen, 2013).  
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In this study, the majority of placenta samples presented levels of HPAHs 
(pyrene and benzo[a]pyrene equivalents) below LOD and due to the low number of 
replicates above LOD in each county, no comparisons were performed between Aveiro 
counties.  
 
2.5. Conclusion 
In conclusion, placenta plays a role as a barrier for PAHs content although it is not fully 
effective, as PAHs levels are still found in blood from the umbilical cord.  In Aveiro 
region, the highest PAHs concentration was found in homogenized placenta 
comparatively to the other matrices. The lowest PAHs concentration was found in 
umbilical cord blood. In this study, the parturient living in Aveiro, Ílhavo and 
Albergaria-a-Velha had the highest concentration of PAHs in the homogenized 
placenta, with Águeda presenting the lowest PAHs concentrations in the same matrix. 
Other demographic and environmental data which may be related to high PAHs 
concentrations in homogenized placenta is the proximity of residence to roads with high 
traffic. In concern to smoke habits, naphthalene, phenanthrene and BaP equivalents 
levels present in homogenized placenta were higher in parturient with smoking habits 
during the last trimester of pregnancy. Although non-significant, alterations in 
anthropometric data were observed in newborns and may be related with higher levels 
of PAHs, with decreases on weight, length and head circumference. Parturient who had 
newborns with less weight had significant higher pyrene equivalents levels in 
homogenized placenta, while smaller newborns presented significant higher BaP levels 
homogenized placenta.  
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2.7 Supplementary Data   
 
Table 2-S1 - Levels of naphthalene, phenanthrene, pyrene and benzo[a]pyrene equivalents 
(expressed in µg/mg protein) in placenta (homogenate fraction). Values represent mean and 
standard deviation (between brackets) of PAHs according to the area residence related 
characteristics reported in the questionnaires by parturient. N-number of replicates. 
 
 
 Naphthalene 
 
Phenanthrene 
 
Pyrene  
 
Benzo[a] 
Pyrene 
 
N (%) N  
HABITATION  
Place of 
residence  
 
Urban  7.87 (3.32) 0.28 (0.14)  0.02 (0.01) * 2.89x10-03 
(0.003)  
40.8% 20 
Rural  8.50 (3.47) 0.30 (0.14)  0.04 (0.03)  2.72x10-03 
(0.0006)  
34.7% 17 
Intermediate 7.88 (3.16) 0.29 (0.11)  0.01(0.0004)  3.76x10-03 
(0.004)  
24.5% 12 
House near 
industrial 
activities 
 
Yes 7.39 (3.37) 
 
0.26 (0.13) 0.03 (0.02) 3.96x10-03 
(0.004) 
30.6% 15 
No 8.31 (3.20) 0.30 (0.12) 0.01 (0.003) 3.04x10-03 
(0.003) 
69.4% 34 
House 
description   
 
Detached 
villa 
detached 
from other 
houses 
6.60 (1.95) 0.23 (0.08) <LOD <LOD 10.2% 5 
Detached 
villa next to 
one or more 
houses 
7.97 (3.45) 0.29 (0.13) 0.03 (0.03) 2.40x10-03 
(0.002) 
46.9% 23 
Apartment  8.57 (3.40)  0.71 (1.79) 
 
 0.02 (0.009) 3.26x10-03 
(0.004) 
38.8% 19 
Other 7.19 (1.84) 0.24(0.07) <LOD  5.78x10-03 
(0.004) 
4.1% 2 
Frequency of 
cars near 
house 
 
Constantly 9.05 (4.28) 0.33 (0.18) 0.02 (0.0084) 4.18x10 -03 
(0.004) 
26.5% 13 
Frequently 8.22 (3.57) 0.29 (0.13) <LOD 1.23x10-03 
(0.0006) 
 
24.5% 12 
Less 
Frequently 
8.43 (2.10) 0.30 (0.08) * 0.01 (0.0004) 1.82x10-03 
(1.18x10-03)  
28.6% 14 
 
 
65 
Almost 
Nothing 
5.92 (1.73) 0.21 (0.06) 0.03 (0.02) 6.17x10-03 
(2.58x10-03) 
20.4% 10 
Frequency of 
heavy road 
vehicles near 
house 
 
Constantly 11.66 (6.14) 0.43 (0.24) <LOD <LOD * 6.1% 3 
Frequently 9.36 (3.07) 0.34 (0.12) <LOD 3.56x10-03 
(0.003)  
14.3% 7 
Less 
Frequently 
8.86 (3.10) 0.32 (0.12) 0.01(0.0004) 8.92x10-04 
(5.08x10-04)  
28.6% 14 
Almost 
Nothing 
6.76 (2.47) 0.24 (0.10) 0.03 (0.02)  4x10-03 
(0.003)  
51.0% 25 
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Table 2-S2 - Spearman correlations between levels of naphthalene, phenanthrene, pyrene and BaP 
equivalents in biological matrices and cotinine levels in mothers’ plasma.  
 
PAHs Tissues  r P value N 
Naphthalene  Homogenized 
placenta 
-0.0751 0.607 49 
 Umbilical 
cord cells 
 
-0.0286 0.916 14 
Phenanthrene  Homogenized 
placenta 
-0.0591 0.685 49 
 Supernatant 
placenta  
 
0.829 0.05 6 
 Umbilical 
cord 
cells 
 
-0.2333 0.520 9 
 Umbilical 
cord plasma 
 
0.0115 0.948 32 
 Mother 
plasma 
-0.464 0.00486 36 
Pyrene  Homogenized 
placenta 
-0.236 0.490 10 
 Supernatant 
placenta  
 
-0.333 0.387 8 
 Umbilical 
cord plasma 
 
-0.167 (0.643 9 
 Mother 
plasma 
-0.165 0.949 13 
Benzo[a]Pyrene Homogenized 
placenta 
0.0220 0.935 13 
 Supernatant 
placenta  
 
0.200 0.783 5 
 Umbilical 
cord plasma 
 
0.0549 0.849 13 
 Mother 
plasma 
-0.385 0.186 13 
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Table 2-S3 - Levels of naphthalene, phenanthrene, pyrene and benzo[a]pyrene equivalents 
(expressed in µg/mg protein) in placenta (homogenate fraction). Values represent mean and 
standard deviation (between brackets) of PAHs according to smoking habits and/or tobacco smoke 
exposure during pregnancy reported in the questionnaires by parturient. N-number of replicates. 
 
 Naphthalene 
 
Phenanthrene 
 
Pyrene  
 
Benzo[a] 
Pyrene 
 
N (%) N  
Passive 
Smoker 
(Restaurants; 
coffee shops)  
 
 
Never 8.17 (3.31) 0.29 (0.13) 0.02 (0.02) 3.25x10-03 
(0.003) 
53.1% 26 
Sporadically 6.77 (2.39) 0.24 (0.10) <LOD <LOD 34.7% 17 
Daily 
(1hour) 
<LOD <LOD <LOD <LOD 6.1% 3 
Daily 
(+3hours) 
<LOD <LOD <LOD <LOD 6.1% 3 
House  
Never 7.86 (2.99) 0.28 (0.12)* 0.02 (0.02) 3.04x10-03 
(0.003) 
77.6% 38 
Sporadically 7.83 (2.65) 0.30 (0.11) <LOD  <LOD 6.1% 3 
Daily 
(±1hour) 
 6.26 (1.16) 
 
 0.21 (0.05) 
 
<LOD 
 
<LOD 
 
8.2% 4 
Daily 
(+3hours) 
11.52 (5.59) 0.42 (0.22) <LOD 1.30x10 -03 
(6.79x10-05) 
8.2% 3 
Work Place  
Never 8.78 (2.79) 0.31 (0.11) 
 
0.02 (0.01) 3.97x10-03 
(0.004) 
91.8% 45 
Sporadically 6.83 (2.90) 0.24 (0.12) 0.03 (0.02) 3.21x10-03 
(0.003) 
4.1% 2 
Daily 
(1hour) 
5.75 (2.01) 0.20 (0.07) <LOD <LOD 2.0% 1 
Daily 
(+3hours) 
10.64 (6.85) 0.38 (0.27) <LOD 2.48x10-03 
(0.001) 
2.0% 1 
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Table 2-S4 - Levels of naphthalene, phenanthrene, pyrene and benzo[a]pyrene equivalents 
(expressed in µg/mg protein) in placenta (homogenate fraction). Values represent mean and 
standard deviation (between brackets) of PAHs according to work place related characteristics 
reported in the questionnaires by parturient. N-number of replicates. 
 
 Naphthalene 
 
Phenanthrene 
 
Pyrene  
 
Benzo(a)
Pyrene 
 
N (%) N  
WORK 
PLACE  
 
Occupation  
Unemployed 8.62 (2.67) 0.89 (1.70) <LOD 3.99x10-03 
(0.003) 
38.8% 19 
Employed 7.76 (3.70) 0.28 (0.14) 0.02 (0.02) 2.70x10-03 
(0.002) 
55.1% 27 
Student 6.74 (1.82) 0.21 (0.14) <LOD <LOD 6.1% 3 
Where is the 
occupation  
    
Aveiro 7.76 (3.18) 0.27 (0.12) 0.03 (0.02) 3.45x10-03 81.6% 40 
Outside 
Aveiro 
8.51 (1.52) 0.31 (0.04) 0.02 (0.01) <LOD 8.2% 4 
Other 9.75 (5.30) 0.36 (0.20) 0.01 (0.002) <LOD 10.2% 5 
What was 
your last 
occupation  
 
Student 8.50 (3.43) 0.31 (0.12) 0.03 (0.02) 2.44x10-03 
(0.003) 
40.4% 19 
Work in 
same area 
7.16 (3.88) 0.25 (0.15) <LOD 
 
<LOD 10.6% 5 
Commerce 
work 
7.47 (3.82)  0.26 (0.16) 0.02 (0.01) 2.00x10-3 
(0.001) 
23.4% 11 
Other 7.93 (2.51) 0.28 (0.10) <LOD 5.78x10-3 
(0.004) 
25.5% 12 
Exposure to 
chemicals in 
workplace 
 
Yes 7.79 (2.61) 0.28 (0.10) 0.03 (0.02) 4.39x10-3 
(0.02) 
46.9% 23 
No 8.25 (3.68) 0.29 (0.14) 
 
0.03 (0.004) 2.15x10-3 
(0.003) 
53.1% 26 
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3.1 Final Remarks  
 
Epidemiological studies are multidisciplinary studies that rely on different areas 
of research, from chemistry to biology and medical disciplines that perform human 
monitoring in order to understand patterns, causes, and effects on human health and 
disease development. The use of invasive and/or non-invasive matrices to assess human 
exposure to environmental contaminants is of upmost relevance. For the first time, a 
cross-sectional study concerning pre-natal exposure to PAHs was performed in Aveiro 
district, Portugal, an urban region with 78455 habitants, according to INE (Instituto 
Nacional de Estatística) (2001) and also with highly industrialized areas. 
Aveiro, Ílhavo, and Albergaria-a-Velha were the counties of parturient residence 
presenting the highest levels of PAHs in placenta, while those from Águeda presented 
the lowest PAHs levels. Furthermore, higher LPAHs levels in placenta were associated 
with parturient residence near traffic roads (higher traffic exhaust). Aveiro and Ílhavo 
have in fact higher urban and industrial areas where PAHs emissions are more prone to 
occur. However, to better depict the main drivers accounting for the differences in 
PAHs levels among the different counties a higher number of mothers/newborn pairs 
from each county should be studied in the future. A higher and representative number of 
parturient from each municipality (e.g. in the present study N=3 from Albergaria-a-
Velha; N=5 Estarreja) will help to understand and determine the main PAHs 
sources/emissions for each municipality. 
In this research study, one of the main goals was to examine the influence of 
variables accounting for the levels of naphthalene, phenanthrene, pyrene and BaP 
equivalents in the biological matrices analyzed. Namely, tobacco exposure at work and 
traffic exhaust accounted for 15.2% of the variability observed in PAHs levels. There 
are other environmental and lifestyle variables that can account for the PAHs levels 
observed in parturient placenta and blood, namely mothers’ eating habits. PAHs may 
occur in food preparation (e.g. grilled food), conservation and storage. PAHs levels 
were found in some products such as dried fruits, olive pomace oil, smoked fish, grape 
seed oil, smoked meat products, fresh mollusks, spices/sauces and condiments (Buckpitt 
et al., 2002; Yu et al., 2011).  Therefore, in future studies the relation of PAHs levels 
present in placenta, umbilical cord blood and mothers’ blood and parturient eating 
habits should be explored.  
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In the last decade, Portugal has been one of the most affected European 
countries with forest fires (JRC, 2015), with 2017 being considered the worst year in the 
last decade. It is expected that due to climatic changes, these natural catastrophes will 
even tend to increase exposure in human populations to high concentrations of PAHs 
through air. In this context, it would be relevant to perform regular human 
biomonitorization studies in critical burned areas of Portugal in order to understand if 
forest fires are contributing to PAHs levels in placenta, umbilical cord blood and 
parturient’ blood.  
There are several studies that use PAHs levels in placenta and blood as 
biomarkers of exposure in pregnant women and their newborns (Al-Saleh et al., 2013; 
Machado et al., 2014; Chen et al., 2014; Zhang et al., 2017). Blood and placenta are 
good matrices for PAHs levels measurements. Placenta is a large non-invasive matrix 
that can trace possible PAHs partial bioaccumulation because of their lipophilic 
properties and can provide possible information about the mothers’ exposure to PAHs 
levels. In this research the highest PAHs levels were found in placenta. Placenta had 
higher PAHs levels than umbilical cord and mothers’ blood. Umbilical cord and 
parturient blood can supply significant information about mothers’ and fetus exposure. 
Since these matrices allow us to obtain information about the PAHs levels in the human 
organism, an indicative and/threshold levels would be of extreme relevance to develop 
or adapt for placenta and blood matrices in order to assess the risk of exposure of the 
studied populations based on the obtained PAHs levels.  
However, the use of different methodologies to quantify PAHs turns difficult the 
comparison of pre-natal exposure among the different populations studied. The 1OH-
Pyrene, metabolite of pyrene quantified in urine, is the most used biomarker of exposure 
to PAHs. It is commonly used to assess total burden of PAHs in occupational groups; a 
level of about 0.5 µmol 1OH-Pyrene /mol creatinine in urine is considered indicative of 
occupational exposure to PAHs by the American Conference of Governmental 
Industrial Hygienists (ACGIH, 2010). The quantification of PAHs metabolites in urine 
might be a helpful non-invasive biomarker of exposure to characterize parturient 
exposure to PAHs and to complement data obtained in placenta and blood matrices. 
Considering the different methodologies commonly used for PAHs 
quantification in human biological matrices, the establishment of a standard 
methodology for PAHs measurement is pertinent and will allow for comparisons 
between populations of different countries and under different environmental and 
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anthropogenic pressures. In the present study, the PAHs quantifications were performed 
using fixed fluorescence wavelength methodology. However, there are other PAHs 
methodologies like HPLC and GC-MS. In future studies, it would be interesting to 
compare the PAHs measurements performed through the different techniques.   
Biomarkers of exposure have shown to be essential tools to study the 
relationship between environmental exposure and health and disease development. 
Besides in the present study no significant correlations were found between PAHs 
levels in placenta and anthropometry data of newborns, in general, higher levels of 
PAHs were found in groups of newborns with less weight, height and cephalic 
perimeter. Taking these results into account, further longitudinal or cross-sectional 
studies should be conducted regarding intrauterine exposure to PAHs, which may affect 
the fetal development, in order to prevent negative outcomes in Portuguese populations 
and offspring. 
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